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ABSTRACT 
 
NK-lysin is a cationic antimicrobial peptide (AMP) of the host innate immune system 
and active against a broad spectrum of targets, including bacteria, viruses, fungi and 
cancer cells. NK-lysin has been well-studied in humans and pigs, in which each genome 
contains a single copy of NK-lysin. However, the bovine genome has received much less 
attention with only one study, in which two 405-bp Bo-lysin fragments with 94% 
nucleotide identity were detected among four experimental donors. These two sequences 
likely represent two different bovine NK-lysin genes. The purpose of the present study 
was to characterize the gene number and the genomic organization of bovine NK-lysins 
and their roles in host resistance to pathogens, including pathogens involved in bovine 
respiratory diseases (BRD).  
 
Two overlapping BAC clones (CH240-372P1 and CH240-27G22) covering the whole 
bovine NK-lysin region were sequenced by PacBio (Seattle, WA) and the assembled 
supercontig revealed four NK-lysin genes on cattle chromosome 11. NK2A, NK2B and 
NK2C are tandemly arrayed as three copies in 30 ~ 35 Kb segments, located 41.8 Kb 
upstream of NK1. All four genes are functional, albeit with differential tissue expression. 
NK1, NK2A and NK2B exhibited the highest expression in intestine Peyer’s patch while 
NK2C was expressed almost exclusively in lung. Four peptides corresponding to the 
functional helices 2 & 3 of each gene product were synthesized. Circular dichroism (CD) 
spectroscopy demonstrated that peptides adopted a more helical secondary structure 
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upon binding to an anionic model membrane, and a liposome leakage assay suggested 
that these peptides disrupt the model membrane. To test the potential role in host 
response to BRD pathogens, we analyzed RNA-seq data to determine expression of each 
NK-lysin gene in bronchial lymph node and lung in healthy animals and animals 
challenged with BRD pathogens. The expression of some NK-lysins, especially NK2C, 
was significantly elevated in most of the challenged animals, indicating potential 
functions in BRD resistance. Antimicrobial effects of the synthetic peptides against 
Escherichia coli, Staphylococcus aureus, Pasteurella multocida and Mannheimia 
haemolytica were further confirmed with bacterial killing assays, and their lytic 
influences on cell membranes were confirmed by transmission electron microscopy 
(TEM).  
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AMP Antimicrobial Peptide 
CNV Copy Number Variation  
SD Segmental Duplication 
SNP Single Nucleotide Polymorphism 
CD Circular Dichroism 
INDEL Insertion/Deletion 
BRD Bovine Respiratory Disease 
BVDV Bovine Viral Diarrhea Virus 
BRSV Bovine Respiratory Syncytial Virus 
IBR Infectious Bovine Rhinotracheitis       
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CHAPTER I 
INTRODUCTION  
                                                                                 
Cattle: domestication and agricultural importance 
Cattle are one of the most common domesticated animals and have significant roles in 
agriculture throughout the world. Different breeds of cattle have evolved for specialized 
purposes, including beef cattle for meat, dairy cattle for milk and draft cattle for drawing 
loads. Other secondary products from cattle include clothing from hides, fertilizer from 
dung and tools from bones and hoofs. Two major lineages of cattle, the humpless taurine 
cattle B. taurus and the humped zebu cattle B. indicus, share a most recent common 
ancestor approximately 1.7 – 2.0 million years ago [1]. Most commercial cattle breeds in 
developed countries are descended from the taurine lineage, however, it is a common 
practice to hybridize purebred taurine cattle and zebu to enhance host resistance to 
pathogens or performance in harsh environments [2-4]. 
 
The domestication of animals and plants was an important step in human history, 
because it allowed a shift from nomadic to semi-settled or settled lifestyle [5, 6]. 
Archaeological and genetic analysis suggested that the taurine and zebu cattle were 
independently domesticated around 10,500 years ago from the same ancestor species, the 
auroch (Bos primigenius) which has been extinct since 1627 [7]. Domestication of cattle 
occurred in two major regions, the Near East (Turkey) where Bos taurus was 
domesticated and the Indian subcontinent (Pakistan) giving rise to the zebu cattle [8, 9]. 
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Some scholars have proposed a third domestication event from the North African 
aurochs giving rise to the African taurine cattle [10, 11].    
 
The first cattle in the Americas originated from Portugal and Spain and were brought to 
the Caribbean island of Hispaniola by Christopher Columbus in 1493. Cattle continued 
to be imported to the Americas by the Spanish colonists until 1512. In 1512, Caribbean 
cattle were introduced to Mexico and later moved to Texas, and these Spanish cattle are 
believed to be the ancestors of the current New World cattle breeds [12], such as the 
Texas Longhorns which are resistant to cattle tick fever, the Mexican Corriente cattle 
and the Colombian Romosinuano cattle. Spanish cattle were the only cattle in the North 
America for several hundred years until 1860s, when the indicus cattle were imported 
via Jamaica, and gene flow from these indicus cattle into the New World cattle began 
[13]. Some British breeds were brought to the United States in the late 1700s through the 
late 1800s and developed into the most common commercial beef breeds in the United 
States, including the Angus and Hereford. These British breeds generally reach the 
mature size at an earlier age with a smaller mature size than the Continental European 
breeds, have less growth potential and yield carcasses with a lower percentage of 
saleable products, but excel in fertility and calving ease as well as attain higher quality 
grades. To improve the growth rate and leanness of existing breeds, Continental 
European breeds were imported into the U.S. in the late 1960s and early 1970s, 
including the Charolais, Chianina, Gelbvieh, Limousin, Maine Anjou, Salers, and 
Simmental. In comparison to the British breeds, Continental European breeds are 
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generally later maturing with larger mature size, produce carcasses with less fat and a 
higher percentage of saleable products, but have lower quality carcass grades and more 
calving difficulty when mated to cattle of the British breeds. 
 
Antimicrobial peptides 
Antimicrobial peptides (AMPs), also called host defense peptides (HDPs), are small 
cationic molecules consisting of 10 ~ 50 amino acids. These peptides usually contain a 
large proportion of positively charged and hydrophobic residues, which are two major 
determinants of the antimicrobial activities. AMPs are effector molecules in the host 
innate immune system and widespread in both plant and animal kingdoms, suggesting 
evolutionarily conserved roles in multicellular organisms [14-16]. The reservoir of the 
identified AMPs is so diverse that it is difficult to categorize all the molecules into 
completely distinct groups, but they can be broadly divided into five classes on the basis 
of their secondary structures [17]. The first class consists of the anionic peptides, which 
are usually present in the surfactant extracts, bronchoalveolar lavage fluid and airway 
epithelial cells. An example is dermcidin in humans [18]. The second class mainly 
contains the linear cationic peptides without disulfide bonds, exemplified by the silk 
moth’s cecropin and the African frog’s magainin [19, 20]. The third class is composed of 
linear peptides characterized by a predominance of one or two specific residues, such as 
the proline-arginine-rich peptide (PR-39) [21]. Peptides of this group are very flexible in 
solution because they lack of cysteine residues. Cationic peptides that are fragments of 
larger AMP molecules are members of the fourth class. For example, cathelicidins are 
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mature antimicrobial peptides which are part of the C-termini of larger precursors whose 
N-termini share a homology with porcine cathelin [22]. The fifth class includes the 
peptides with six conserved cysteine residues which form three intramolecular disulfide 
bonds. These molecules usually display a defined anti-parallel β-sheet structure, such as 
the mammalian β-defensins [23, 24]. Some researchers suggested an additional class of 
AMPs, most of which belong to the SAPLIP (saposin-like protein) family, that share the 
conserved feature of six invariant cysteine residues and three disulfide bridges and a 
conserved globular fold with five helices, the saposin fold. Members in this class include 
the saposins [25], pulmonary surfactant proteins B [26], acid sphingomyelinases(ASMs) 
[27], acyloxyacyl hydrolases(AOAH) [28], plant aspartic proteases(AP) [29], 
amoebapores [30], countin [31] and the NK-lysin molecules [32, 33] which are the focus 
of this study. 
 
AMPs were discovered in 1939, when Dubos demonstrated that an extract from a soil 
Bacillus strain protected mice from Pneumococci infection [34]. An AMP molecule was 
identified from this extract and named as gramicidin [35]. The first reported AMP 
molecule in animals was a defensin, which was isolated from rabbits in 1956 [36]. Since 
then, a substantial number of natural AMPs have been identified in both prokaryotes and 
eukaryotes on the basis of their antimicrobial activities. Most of these natural AMPs 
exhibit a wide spectrum of antimicrobial activities against Gram-positive and Gram-
negative bacteria [21], fungi [37], viruses [38], protozoa [39] and cancer cells [40]. The 
significance of AMPs in host immune systems is not limited to their broad antimicrobial 
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effects, they are also important regulators of immune responses. The first non-
microbicidal activity of AMPs was reported in 1989 when the neutrophil derived α-
defensins were found to be chemotactic towards human monocytes [41]. Subsequent 
studies demonstrated that these α-defensins were also chemoattractive to 
(CD4+/CD45RA+) CD4+ and CD8+ T cells, immature dendritic cells (iDC), but not to 
memory (CD4+/CD45RO+) T cells [42]. On the other hand, an enhanced IgG antibody 
response was observed when co-administering ovalbumin (OVA) with α-defensins 
HNP1-3 in mice compared to OVA alone [43], indicating a role in the modulation of 
adaptive immunity. Other non-microbicidal activity of an AMP molecule includes its 
ability to inhibit pro-inflammatory responses induced by LPS through suppressing the 
LPS- induced gene expressions in macrophages [44]. AMPs have also been suggested to 
contribute to wound healing. The expression of an antimicrobial gene LL-37 was 
observed to be significantly enhanced in skin wounds in vivo, and decreased to the 
lowest level upon wound closure [45].  
 
The potent antimicrobial activity of an AMP molecule is attributed to its specific amino 
acid composition, including a net positive charge, hydrophobicity and amphipathicity. 
AMPs are proposed to exhibit their antimicrobial effects by forming pores in target 
membranes following three general steps. The first step of every AMP-mediated killing 
is the attraction of the molecule to a target membrane, by the electrostatic interaction 
between the cationic AMP and an anionic target membrane. The negatively charged 
lipopolysaccharide (LPS) and other anionic lipids in the outer membranes of Gram-
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negative bacteria and the teichoic acids of Gram-positive bacteria membranes are all 
targets of cationic AMP molecules. Cancer cells are also the targets of an AMP due to an 
increased fraction of anionic molecules in their cell membranes, such as the 
phosphatidylserine (PS) [46] and O-glycosylated mucins [47]. In contrast, AMPs exhibit 
low cytotoxicity to normal host cells due to the overall neutral charge of their cell 
membranes which are mainly comprised of zwitterionic phospholipids [48].  
 
The second step involves the attachment of an AMP to the target membrane and the 
ensuing occurrence of peptide-membrane interaction, which contains two physically 
distinct states. The target membrane will be stretched at a low peptide/lipid ratio and 
peptides begin to orientate and insert into the bilayers at a high peptide/lipid ratio.  
 
The third step is the pore formation in target membranes caused by AMPs after insertion. 
Three models are proposed to explain this mechanism: the ‘carpet model’, the ‘barrel-
stave model’ and the ‘toroidal-pore model’ [21]. In the ‘carpet model’, peptides 
accumulate in parallel on the membrane, covering the cell surface in a carpet-like 
manner. When the peptide concentration reaches a critical threshold, they begin to 
disrupt the bilayers in a detergent-like manner, resulting in the formation of micelles. In 
the ‘barrel-stave model’, peptide helices form a bundle in the membrane with a central 
lumen, being like a barrel with the peptide helices as the staves. The hydrophobic face 
aligns with the lipid core region of the bilayer and the hydrophilic face form the interior 
region of the pore. In the ‘toroidal-pore model’, the polar faces of the peptides are 
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always associated with the polar head groups of the lipids even when peptides are 
perpendicularly inserted in the lipid bilayers, resulting in the water core lined by both the 
inserted peptides and the lipid head groups. Despite the existence of three proposed 
models, they are related to each other. The interaction between an AMP molecule and a 
target membrane is actually a continuous graduation between three models rather than a 
simple process that can be explained by only one individual model [49]. It is well-known 
that AMPs are multifunctional molecules. In addition to the well-studied killing 
mechanism of pore formation, AMPs can also exhibit their influences on targets through 
other mechanisms, such as inhibition of the synthesis of cell walls, nucleic acids and 
proteins. Peptidoglygan is the main component of cell walls, and an essential structure 
responsible for cell shape in bacteria, especially in the Gram-positive bacteria. In 
contrast, peptidoglygan is not found in eukaryotic cells. Therefore, compounds that can 
inhibit the synthesis of peptidoglygan are strong candidate therapeutic agents for 
bacterial infections without causing damage to host cells. Several AMP molecules 
including the lantibiotics and Lcn972 have been demonstrated to inhibit cell wall 
synthesis by targeting lipid II, an important precursor of peptidoglycan synthesis [50]. 
On the other hand, some AMPs are able to penetrate cell membranes and disrupt the 
synthesis of nucleotide acids or proteins. A 21-residue AMP molecule, Buforin II, was 
shown to cross the cell membrane and bind to DNA and RNA due to sequence identity 
between the N-terminal of histone H2A and buforin II [51]. Indolicidin, puroindoline 
and cathelicidins have also been shown to inhibit the synthesis of nucleic acid and 
protein [52-54]. Besides the mechanism of pore formation in killing cancer cells because 
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of the increased negative charge in the cell membrane, AMPs can also target different 
signaling pathways to provoke cell deaths. For example, magainin can induce cell deaths 
by increasing the levels of ROS and the caspase-3 activity in cancer cell line HL-60, 
while tachyplesin induces cell apoptosis by regulating the intracellular potassium 
concentration in the same cancer cell line [55, 56].  
 
Different from the antibiotics which induce the development of resistance in microbes 
within a short application period and cause potential threats to the public health [57], the 
electrostatic interaction between cationic AMPs and anionic target membranes reduce 
the development of resistance while preserving the efficacy of antimicrobial effects. 
Therefore, AMPs are considered as candidate antimicrobial drugs. However, relatively 
few AMPs actually have proceeded into clinical trials [58]. Only two peptides, 
pexiganan and omiganan [59], demonstrated efficacy in Phase III clinical trials, but are 
still not approved by the US Food and Drug Administration (FDA). Several factors 
inhibit the development of AMPs as antibacterial drugs, including the cost of peptide 
synthesis, resistance to proteolytic degradation and toxicology to host cells [60]. Efforts 
have been made to address each of the factors. For example, a high-throughput system 
was developed to synthesize peptides at low cost and screen large numbers of peptides 
for improved antimicrobial activities [61]. On the other hand, an enhanced resistance to 
proteolytic degradation can be achieved by replacing the natural residues with D-amino 
acids or other non-natural amino-acid analogues. The hemolytic toxicity of a newly 
identified natural AMP or synthetic peptide is usually tested in vitro, and the risk of 
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hemolytic toxicity can be further alleviated by masking the peptides with liposomal 
formulation [62].  
 
Granulysin/NK-lysin 
Human granulysin and pig NK-lysin are cationic antimicrobial peptides in the innate 
immune system and present in the granules secreted by the activated cytotoxic T 
lymphocytes (CTLs) and natural killer (NK) cells [32, 63]. Since the first identification 
of human granulysin by subtractive hybridization in a search for genes expressed by the 
activated T lymphocytes [64]
 
and the isolation of NK-lysin from pig small intestine 
based on its antibacterial activity [63], extensive studies have focused on the 
characterization of these two novel molecules. Single copies of granulysin and NK-lysin 
genes are contained in the genomes of humans and pig. Two splicing isoforms of 
mRNAs for granulysin are identified in humans, the 519 and NKG5, where the NKG5 
lacks the 243-bp second exon of the 519 [65, 66]. In contrast, there is only one reported 
transcript of NK-lysin in pig. The mature porcine NK-lysin molecule is approximately 9 
kDa and consists of 78 residues, which is processed from a 129-residue precursor 
(Accession number: Q29075). The intact NK-lysin molecule contains six conserved 
cysteine residues which form three intrachain disulfide bonds. NMR structure of the 
porcine NK-lysin reveals a saposin fold, which consists of five alpha-helices, 
corresponding to the residues 3-18, 24-37, 42-51, 54-61 and 66-72 respectively. Among 
five helices, helix 1 is located in the core while helices 2 & 3 face one side and helices 4 
& 5 face the other side [67]. 
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Consistent with the broad spectrum of targets of other AMPs, NK-lysin molecules and 
their derivatives are also active against a wide range of microorganisms, including both 
Gram-positive and Gram-negative bacteria [63], fungi [68], protozoa [69], viruses [70] 
and cancer cells [71]. One of the most interesting antimicrobial activities of NK-lysin 
molecules is the capacity to directly kill extracellular Mycobacterium tuberculosis, 
which is particularly resistant to the human immune response [72, 73]. They also exhibit 
potent effects on intracellular Mycobacterium tuberculosis following permeation of the 
cellular membrane by the pore-forming protein perforin [74]. A 22-residue domain 
spanning the helix 3 and a disulphide-constrained loop was suggested to be responsible 
for this anti-mycobacterial activity [73]. In addition to the well-known antimicrobial 
activities, NK-lysin molecules play several other significant roles in maintaining host 
health. NK-lysin can stimulate the insulin secretion without changes in 
cytosolic free calcium concentration, indicating its function in maintaining blood glucose 
homeostasis [75]. Due to the interaction between cationic NK-lysin molecules and 
anionic lipopolysaccharides (LPS) [76], NK-lysin is indicated to alleviate endotoxemia, 
a disease caused by a high level of LPS or endotoxin in the blood. Similar to other AMP 
molecules, NK-lysin and its derivatives exhibit anti-tumor activity with little effects on 
normal host cells [71]. This selectivity of effects is attributed to the electrostatic 
interaction between cationic NK-lysin and anionic phosphatidylserine (PS), an 
increasing level of component on the surface of cancer cells as cancer aggravates [46] 
[77].    
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NK-lysin may possess important functions other than these currently identified. 
Understanding of the multifaceted molecule in host health will be necessary for 
designing therapeutic drugs. However, a NK-lysin counterpart has not been identified in 
the mouse genome [78], precluding the gene silencing study in mice. Identification and 
characterization of this molecule in other animals is essential. NK-lysin orthologs have 
been identified in horse [79], chicken [80] and ruminant species including goat [81], 
water buffalo [82] and cattle [83]. In addition, NK-lysin sequences in two other ruminant 
species, sheep and bison, can be identified in public databases. Bovine NK-lysin was first 
reported a decade ago [83], when two bovine cDNA fragments, Bo-lysin 89 and Bo-lysin 
62, were obtained from each of four different cows. It was unclear whether the detected 
sequences were from two different NK-lysin genes or alleles of a single gene. The aim of 
this study is to characterize the genomic structure, including the gene number and 
genomic organization, of the NK-lysin gene family in cattle, as well as the biological 
function of each family member.   
 
Types of genetic variations  
Genetic variation refers to the diversity of genomes among individuals within a 
population or among different populations. Nucleotide diversity is the percentage of the 
total nucleotides in a genome that differ on average between two individuals in a 
population and is estimated to be 0.1% - 0.4% in the humans [84, 85]. Genetic variants 
can be broadly divided into different forms, including small-scale sequence variation 
(single nucleotide polymorphism and insertion or deletion of a few base pairs) and large-
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scale structural variation (copy number variation, duplication, deletion, translocation and 
inversion).   
 
Single nucleotide polymorphisms (SNPs) are the most common form of genetic variants 
and refer to single nucleotides that vary within a population of individuals. There are 10 
to 30 million SNP sites in the human genome. SNPs within coding regions can be 
divided into three categories on the basis of the functional influences on gene products, 
synonymous SNPs, nonsynonymous SNPs and nonsense mutations. Synonymous SNPs 
are the variants that code for the same amino acids and therefore have no effects on the 
protein sequences. In contrast, a nonsynonymous SNP is the point mutation that codes 
for a different amino acid and displays potential effects on the function of the translated 
protein. For example, sickle-cell disease is caused by a nonsynonymous SNP of A – T 
which results in the substitution of the 6
th
 residue glutamic acid by valine, known as the 
E6V mutation. Another type of point mutation is the nonsense mutation, which codes for 
a premature stop codon leading to a truncated protein. This type of point mutation 
usually shows a strong impact on the protein and results in a nonfunctional gene product. 
A nonsense mutation of C – T within the LGR4 gene causes the termination of LGR4 
protein at the amino acid position 126 and is found to fully disrupt the protein function. 
This mutation is strongly associated with several human traits, including the low bone 
mineral density (BMD), electrolyte imbalance, late onset of menarche, reduced 
testosterone levels and an increased risk of squamous cell carcinoma of the skin and 
biliary tract cancer [86].  
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Another type of small-scale sequence variation is the insertion or deletion of a few base 
pairs, also called an INDEL. An INDEL with a length that is not a multiple of 3 in the 
coding region of a gene produces a frameshift mutation, which will completely change 
the amino acid composition downstream of the INDEL site and thus is very deleterious 
to the gene function. A cytosine insertion within the coding region of NOD2 is 
associated with human Crohn’s disease due to the frameshift and the resulting premature 
stop codon [87]. Therefore, natural selection will purify these deleterious INDELs from 
the coding region of functional genes. As a result, INDELs occur more frequently within 
the intergenic and non-coding regions of genes.  
 
In contrast to the small-scale sequence variation which involves an individual nucleotide 
or a few nucleotides, structural variation usually involves a large genomic region. One of 
the most common structural variations in the human genome is copy number variation 
(CNV), which is defined as the difference in the copy number of a large genomic region, 
ranging from 1 Kb to several megabases, among the genomes of different individuals 
[88]. A CNV can be tandemly organized within the same chromosome region or at 
multiple sites on different chromosomes. Duplications (>1 Kb) that are highly identical 
(90%) are known as low copy repeats (LCRs) or segmental duplications (SDs) based on 
genome sequence analysis between individuals. SDs frequently lead to local genomic 
instability and therefore serve as one of the principal mechanisms of gene family 
expansion [89] and provide substrates for new gene function and development [90, 91]. 
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Both CNVs and SDs have been associated with phenotypic diversity and disease 
susceptibility [92, 93].  
 
Other structural variations include inversions and translocations. In contrast to the gain 
or loss of genetic material of a CNV, an inversion or translocation is considered as a 
balanced structural variation that rearranges the orientation or location of a DNA 
segment rather than changes its copy number. An inversion occurs when a piece of 
genomic fragment is broken twice, flipped 180 degrees, and rejoined. A reciprocal 
translocation is a type of rearrangement in which two nonhomologous fragments 
exchange the locations. Both forms of structural variations can lead to phenotypic 
diversity including genetic diseases. For example, a recurrent 400 Kb inversion in the 
factor VIII gene is associated with human Hemophilia A [94], and a Robertsonian 
translocation of the chromosome 21 long arm to the long arm of chromosome 14 is 
responsible for 2 – 4% of the Down syndrome [95].  
 
Mechanism of CNV and SD formation  
Homologous recombination (HR) is a biological mechanism for DNA repair. Deletions 
or duplications will not occur if a damaged DNA fragment is repaired using the 
homologous sequence at the same chromosomal position on the homologous 
chromosome as the template. However, recombination between homologous sequences 
at different chromosomal positions or non-allelic homologous recombination (NAHR) 
sometimes occurs. NAHR is one of the major contributors to genome rearrangement and 
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is mediated by highly homologous pre-existing repeats or previously duplicated regions 
such as the SDs [96-98]. A large number of the identified breakpoints associated with 
recurrent rearrangements are embedded within these repeat elements or SDs [99]. 
During meiosis, misalignment and subsequent crossing-over can occur between DNA 
fragments with high sequence identity at different chromosomal positions on each 
chromosome, producing gametes with different copies of the fragment between the two 
NAHR sites. The minimal nucleotide tract length with high sequence identity to each 
other required for an efficient initiation of recombination is defined as the minimal 
efficient processing segments (MEPS). The length of MEPS for an occurrence of NAHR 
during meiosis ranges from 300 – 500 bp, thereby usually resulting in large CNVs [100]. 
 
Non-homologous end joining (NHEJ) is another common DNA repair mechanism, 
which rejoins the ends of a double-strand break (DSB) without the requirement of a 
homologous template [101]. In general, NHEJ repairs a broken DNA fragment 
accurately with gain or loss of very little sequences at both broken ends, maintaining the 
genomic stability [102]. However, mutations in some of the genes that are involved in 
DSB repair pathways including  RAD50, XRS2 and MRE11 can significantly increase the 
frequency of extensive deletions at the broken ends in Saccharomyces cerevisiae [101]. 
On the other hand, insertions of extrachromosomal DNA sequences, including the 
mitochondrial DNA fragments and retrotransposons, at the broken ends are also reported 
[103, 104]. In humans, NHEL is suggested as the predominant contributor to the 
interchromosomal recombination and segmental duplication in subtelomeres, associated 
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with primate evolution [105]. In contrast to NHEJ which does not require sequence 
homology to guide the repairing, microhomology-mediated end joining (MMEJ) repairs 
a DNA break by identifying a microhomology of 5- 25 complementary base pairs on 
both strands and leads to a deletion of the sequence between the annealed 
microhomologies [106].  
 
The presence of microhomology at the non-homologous recombination site has usually 
been regarded as the signature of non-replicative MMEJ repair pathway. Recently, 
increasing evidence implicates that the formation of microhomology at a DNA broken 
site is also linked to DNA replication pathway and thus a novel mechanism of CNV 
formation involving the fork stalling and template switching (FoSTeS) has been 
proposed [107, 108]. Since a double-strand DNA break is more likely to induce a 
recombination-based DNA repair, including the NAHR, NHEJ and MMEJ, a single-
strand DNA (ssDNA) lesion rather than a double-strand break is proposed as the 
initiating damage in the FoSTeS model. This ssDNA break can cause the stalling of 
replication forks and successive template-switching to repair the DNA breaks, but results 
in structural variations due to the errors at replication forks.    
 
Although multiple models have been proposed for the occurrence of a copy number 
change variant, a single model is usually not enough to account for a given event. 
Instead, multiple mechanisms work together at different timelines to lead to a 
duplication or deletion event. For example, a NAHR event might trigger the breakage-
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fusion-bridge cycle by forming a dicentric chromosome, and the fusion step might be 
mediated by an end-joining mechanism. Also, end-joining mechanisms are important in 
repairing the broken ends that result from other events [106].   
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CHAPTER II 
GENOMIC ORGANIZATION OF THE BOVINE NK-LYSIN GENE FAMILY 
*
 
 
Introduction 
Copy number variation (CNV) is a form of structural genomic variation, usually as a 
deletion or a duplication, ranging from 1 Kb to several Mb. CNV is very common in 
animal genomes, where it covers ~12% of the human genome and is a major contributor 
to phenotypic diversity [88, 109-112]. In contrast to the single nucleotide 
polymorphisms (SNPs), CNVs involve large chromosomal regions with the potential for 
substantial impact on phenotypes and have been associated with a large number of 
genetic disorders [113-115]. Duplications (>1 Kb) that are highly identical (90%) and 
exist at multiple locations interchromosomally or intrachromosomally are defined as 
segmental duplications (SDs). Since SD segments are large in size and share high 
sequence identity to each other, they often result in chromosomal rearrangements and 
thus genome instability. Many multigene families are proposed to arise by segmental 
duplications and subsequent functional differentiations, including those with uniform 
members such as ribosomal RNA genes and those with variable genes like 
immunoglobulins. Several whole genome CNV distribution analyse have been 
performed among different breeds of cattle, and two independent studies suggested that 
the bovine NK-lysin gene is located in a copy number variation region (CNVR) [112, 
                                                 
*
Reprinted with permission from “Bovine NK-lysin: Copy number variation and functional 
diversification” by Chen J, et al, 2015. Proc Natl Acad Sci U S A, 112(52):E7223-9, Copyright [2015] by 
the National Academy of Sciences of the United States of America. 
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116]. A search of the National Center for Biotechnology Information (NCBI) bovine 
nucleotide database identified seven different NK-lysin related sequences (Table 1), and 
a phylogenetic analysis of these sequences showed four clades that potentially 
represented four different bovine NK-lysin genes. We designated these genes, NK1, 
NK2A, NK2B and NK2C (Fig. 1). NK2A, NK2B and NK2C are closely related to each 
other while NK1 is more divergent. The genes corresponding to NK1 and NK2A have 
previously been annotated as uncharacterized LOC616323 [Gene ID: LOC616323] and 
Bovine GNLY [Gene ID: 404173], respectively in the bovine reference genome assembly 
UMD 3.1 (UCSC genome browser). These two genes are tandemly arranged on 
chromosome 11, while NK2B and NK2C are not included in the current genome 
assemblies. The assembly of the bovine NK-lysin region in the current genome 
assemblies is likely collapsed due to the duplications. Resequencing this region with 
deep coverage and long sequencing reads is necessary to resolve the correct genomic 
organization of this gene family. 
 
The advent of next-generation sequencing (NGS) technology significantly reduces the 
sequencing cost and thus advances the de novo sequencing of a new species as well as 
improving the genome assembly of a sequenced species. However, one of the biggest 
disadvantages of this widespread technology is the difficulty in assembling a repetitive 
region due to the short length of the reads that are not long enough to span the repetitive 
region. As a result, the inability of these short reads to scaffold across repetitive regions 
results in gaps and incomplete assemblies [117]. Single molecule real time sequencing 
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(SMRT) is one of the latest sequencing technologies and was commercialized by the 
Pacific Biosciences in 2011. In contrast to the short reads from NGS technologies, 
SMRT sequencing can generate extraordinary long reads with most reads > 14 Kb, 
which enables the correct assembly of a complex repetitive region of the genome [118, 
119].   
 
 
Table 1. List of seven different variants of bovine NK-lysin sequences and the 
corresponding accession numbers from the NCBI nucleotide database.   
 
Sequences Accession Cluster 
mRNA-1 XM_005192449 NK2A 
mRNA-2 XM_005192450 NK2A 
mRNA-3 BC114176 NK2B 
mRNA-4 AY245798 NK2A 
mRNA-5 BC114178 NK2C 
mRNA-6 AY245799 NK2C 
mRNA-7 NM_001046578 NK1 
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Figure 1.  Phylogenetic analysis of seven different bovine NK-lysin related mRNA 
sequences (mRNA-1 – 7) from NCBI nucleotide database. Bootstrap values are shown at 
branch points. 
 
 
 
Materials and methods 
Confirmation of NK-lysin inclusion in the BAC clones 
Two overlapping BAC clones covering the bovine NK-lysin region were identified from 
the NCBI clone database and selected from the bovine CHORI-240 BAC library 
(http://bacpac.chori.org/bovine240.htm). Confirmation of the NK-lysin inclusion in the 
BAC clones was conducted with the Bo-lysin primers (Table 2) which were designed 
within the conserved region of NK-lysin reference sequences. Briefly, DNA of each 
BAC clone was extracted using the ZR BAC DNA Miniprep Kit (Zymo Research). The 
extracted BAC DNA was then used as the template in a PCR reaction with the mixture 
of reagents including 5 * PCR buffer, 0.2 µM each of the forward and reverse Bo-lysin 
primer, 0.8 mM dNTPs, 1µL (1.25 U/µL) PrimeSTAR GXL DNA polymerase (Takara), 
25 ng BAC DNA and water to bring the volume to 50 µL. Amplification was carried out 
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in the condition that includes 30 cycles of 10 s at 98 ℃, 15 s at 62 ℃, 20 s at 68 ℃, and a 
final extension of 5 min at 68 ℃. Amplicons were purified using QIAquick PCR 
Purification Kit (Qiagen) and cloned into pCR™4Blunt-TOPO® vector (Life 
Technologies). Fifteen colonies from each BAC were inoculated and cultured overnight 
in 700 µL LB broth with 50 µg/mL ampicillin. Plasmid DNA was extracted using the 
PureLink® Quick Plasmid Miniprep Kit (Invitrogen) and sequenced with the BigDye 
Terminator v1.1 Cycle Sequencing Kit (Applied Biosystems).  
 
BAC sequencing with SMRT technology 
BAC clone sequencing was carried out with the SMRT technology (Pacific Biosciences, 
Seattle, U.S.A), as described previously [119]. Briefly, BAC DNA was sheared to 
generate fragments of approximately 20 Kbp, which were then ligated with hairpin 
adaptors at both ends to construct the sequencing libraries using the PacBio DNA 
Template Prep Kit 2.0 (10 Kbp), followed by the purification with (0.405X) Agencourt® 
AMPure® beads. The sequencing reactions were performed with P4/C2 chemistry on a 
PacBio RS. Each clone was sequenced twice in two separate SMRT cells. De novo 
assembly of the data from each SMRT cell and from the two combined SMRT cells from 
each clone was performed following the standard SMRT Analysis (v. 2.0.1) pipeline. A 
further de novo assembly was attempted using combined data from all four SMRT cells, 
and the final contigs were joined into a single supercontig using Sequencher. The 
supercontig was then compared with the reference sequence (UMD 3.1.1 assembly) 
using the miropeats alignment in Parasight [120], and further dotplot analysis of the 
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supercontig was implemented by UniproUGENE [121, 122]. Four pairs of primers 
specific for each putative junction point (JP-1, JP-2, JP-3 and JP-4) were tested in the 
genomic DNA of L1 Domino 99375 to validate the BAC assembly.  
 
Repeat element analysis 
Repeat elements within the Bo-NK supercontig and the UMD_3.1.1 assembly were 
identified and annotated using CENSOR with a bovine specific library downloaded from 
Repbase that included ancestral sequences [123, 124]. To estimate the density of each 
repeat family within the whole genome assembly (UMD_3.1.1), the assembled 
chromosomes were broken into different bins of the same size as the Bo-NK contig (~ 
227 Kb) and those consisting of > 10% gaps were excluded from the analysis. Repeat 
density for each repeat family with > 5 copies in a bin was represented by the repeat 
coverage per 1000 bp. Ambiguous repeat elements at boundaries were assigned to bins 
based on a minimum 50% repeat length overlap threshold. Overlaps between repeats and 
bins were identified using the Genomic Ranges package from Bioconductor [125, 126]. 
Repeat densities across all bins were used to estimate the empirical cumulative 
distribution function of each repeat family using the “ecdf” command in R and 
Bioconductor [127], which was then used to estimate the probability of sampling a bin 
with repeat density greater than the repeat density of the Bo-NK supercontig (P(X > x)). 
A repeat family was overrepresented in the Bo-NK supercontig if P(X > x) was < 0.05. 
Finally, repeat annotation plots were generated using the base graphics system in R 
[127]. 
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Table 2. Primer information 
 
Primers Forward (5' to 3') Reverse (5' to 3') 
Bo-lysin  ACCCAGCACTCCCACTG ACATACCTGGCTTGCTTTTG 
JP-1  CTAAGTGGCCGGATTGTTGT CAGGGTCTTCTCCTCTGACG 
JP-2  GAAATGCTCTCACAGCAACA AATAGCAATGAAATGATGATGGT 
JP-3  AAAATGCTCTCACAGCAATGAA AATAGCAATGAAATGATGGTAGCTG 
JP-4  GATAGTCTCCCCAACCAGTCAG GAATTGCTGAGCTGGAAGAAGT 
BP-1  GCCTGCCTTCATGGAGTTTA TGGCACAGGTAATGGGATAA 
 
Results 
NK-lysin has expanded to a four-gene family in cattle    
To avoid complexity resulting from allelic variation, BAC clones were used in this study. 
The precise number of genes in the bovine NK-lysin family and their genomic 
organization was determined by sequencing two overlapping BAC clones (CH240-
372P1 and CH240-27G22) covering the NK-lysin region (Fig. 2). Despite a sequencing 
coverage depth of > 700 X for both BACs after the first-round of sequencing, each BAC 
was assembled into six contigs because of the presence of highly repetitive sequences. 
After a second-round of sequencing, the average coverage was increased to 1310 ~ 1551 
X, however, three contigs were still generated for CH240-372P1 and two contigs were 
generated for CH240-27G22. Since these two BAC clones were overlapping, a final de 
novo assembly of all sequencing data was performed. This analysis produced a two-
contig assembly where the two contigs were overlapping by ~ 2 Kb at 100% identity and 
were subsequently joined into a single contig. This resulted in a linear supercontig of 
227,063 bp covering the whole bovine NK-lysin region. Overall, the assembled contig 
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(Bo-NK) was longer than the current genome assembly by ~ 38 Kb, where the 
corresponding reference sequence was 189,124 bp (Bos_taurus_UMD_3.1 Chr. 11: 
48,986,139 – 49,175,262 bp). The difference in length was primarily due to 
misassemblies in the reference genome, in which repetitive regions containing the NK2B 
and NK2C genes, were collapsed (Fig. 3). 
 
 
 
 
 
 
 
 
Figure 2. BAC clone information. Two overlapping BAC clones (CH240-372P1 and 
CH240-27G22, highlighted by red box) were placed against the Bos_taurus_UMD_3.1.1 
assembly to cover the whole NK-lysin region. Two annotated bovine NK-lysin genes, 
LOC100300483 and LOC616323 are indicated by black arrows. 
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Figure 3. Sequence comparison between the Bo-NK supercontig and the genome 
assembly (Bos_taurus_UMD_3.1.1). Mismatches (vertical blue lines), internal 
duplications (grey box) and four NK-lysin gene loci (blue arrows) are indicated. 
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Figure 4. Dotplot analysis of the Bo-NK supercontig against itself. Three segmental 
duplicate fragments are revealed: SD-NK2A: 62.1-97.1 Kb, SD-NK2B: 97.1-130.1 Kb and 
SD-NK2C: 130.1-160.3 Kb. 
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Bovine NK-lysin gene family arose by tandem segmental duplications    
Dotplot analysis of the Bo-NK supercontig against itself revealed three segmental 
duplications (SDs) with ~ 95% sequence identity (SD-NK2A: 62.1-97.1 Kb, SD-NK2B: 
97.1-130.1 Kb and SD-NK2C: 130.1-160.3 Kb), each containing one NK-lysin gene, and 
NK1 was 41.8 Kb downstream from the NK2C gene (Fig. 4). Since the SD-NK2C lacked 
the right end of the duplicated fragment and was shorter than SD-NK2A and SD-NK2B, 
the flanking sequence of junction point-4 (JP-4) was different from the other three 
breakpoints, JP-1 – JP-3 (Fig. 5). To confirm the accuracy of the Bo-NK contig, four 
primer pairs at each junction point were tested using genomic DNA of L1 Domino 
99375 (donor for the CHORI-240 Bovine BAC Library). Sanger sequencing showed that 
JP-1, JP-3 and JP-4 PCR products were perfectly aligned with the Bo-NK contig, while 
there were six mismatches out of 567 nucleotides between the JP-2 PCR product and the 
Bo-NK contig. Another primer pair (BP-1) was tested in order to determine whether 
these six mismatches were due to error in the Sanger sequencing or PacBio sequencing. 
Sanger sequencing verified six sequencing errors at the BP-NK12 breakpoint in the Bo-
NK contig. The Bo-NK contig therefore represented the correct assembly of the bovine 
NK-lysin region, and demonstrated that four NK-lysin genes are located in this region on 
cattle chromosome 11. Complete genomic sequences of four NK-lysin genes were 
compared to determine genetic organization and structure (Fig. 6). All four bovine NK-
lysin genes contain five exons consistent with the human and pig orthologs. The exon 
sizes were comparable among four genes whereas the sizes of the introns of NK1 were 
larger than introns from the other genes, accounting for a larger genomic size of NK1 
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(Fig. 6A). NK2A, NK2B and NK2C are about 95% identical to each other, but only 85% 
identical to NK1. The predicted amino acid compositions of the four bovine NK-lysins 
show high sequence identity and include six invariant cysteine residues, conserved 
among NK-lysin molecules in other animals (Fig. 6B). Phylogenetic analysis of the full 
coding sequences of four bovine NK-lysins with NK-lysin orthologs in humans, pig, 
horse, sheep and goat revealed that NK-lysin gene family expansion is only in the 
ruminants, suggesting the divergence of NK1 and NK2 cluster in the ancestor of cattle, 
sheep and goats (Fig. 7).  
 
 
 
 
 
 
Figure 5. Genomic organization of the bovine NK-lysin gene family and identified 
breakpoints. The flanking sequence of JP-2 was used as the reference sequence. 
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Figure 6. Genomic structure and predicted amino acid sequence were compared 
among four bovine NK-lysin genes. (A) Size comparison of five exons and four introns 
(B) Comparison of the predicted amino acid compositions. The amino acid sequence of 
NK2A was used as the reference, six conserved cysteine residues were indicated. 
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Figure 7. Phylogenetic analysis of the full coding sequences of four bovine NK-lysins 
and NK-lysin orthologs in humans, pig, horse, sheep and goat. The accession number 
for each sequence in the NCBI nucleotide database is indicated and the bootstrap 
values are shown at branch points. 
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Repetitive sequences analysis within bovine NK-lysin gene family 
Repetitive sequences are usually associated with recombination hotspots in human [128], 
and chromosomal instability caused by mispairing between such repeats at breakpoints is 
responsible for several diseases [129, 130]. To gain more insights into the mechanism of 
NK-lysin expansion in cattle, we analyzed the distribution of repeat elements (REs) 
within this region. The distributions of different repeat classes within the assembled 
contig are shown in Figure 8A and summarized in Table 3. Overall, the downstream 
region of each breakpoint is more repetitive than upstream, and the flanking sequences 
of NK1 are highly repetitive, consisting of a large percentage of LINES, which is distinct 
from the rest of the region within this gene family. Several repeat families are 
overrepresented within the NK-lysin region, including two ancient mammalian L1 
families, two LTR families and four ruminant/bovine specific SINEs (BOVTA, 
BTALUL2, CHR-2_BT, and CHR-2A families) (Fig. 9). Due to the enrichment of 
SINEs around junction points, we plotted the distributions of several ruminant/bovine 
specific repeat families between 5 Kb upstream and downstream of each junction point 
(Fig. 8B). The adjacent downstream regions of JP-1, JP-2 and JP-3 are enriched with 
SINES, especially the BOVTA element. BOVTA elements form a bovine specific repeat 
family analogous to the primate repeat ALU family, which are usually associated with 
segmental duplications in humans [96]. These results demonstrate that the fragments 
flanking breakpoints share high homology, and could contribute to unequal crossover 
during meiosis and structural instability within the bovine NK-lysin gene family. 
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Table 3. List of the repeat classes within the assembled Bo-NK contig and the 
corresponding frequencies. Totals in each category are underlined in the Frequency 
column. ERV, endogenous retrovirus; hAT, histone acetyltransferase; RTE, 
recombinational telomere elongation. 
 
 
Class Superfamily  Family Frequency 
LINEs 
  
147 
 
L1 
 
102 
  
HAL1 3 
  
L1_BT 3 
  
L1-2_BT 22 
  
L1-3_BT 13 
  
L1-BT 1 
  
L1MA10 12 
  
L1MB6_5 4 
  
L1MB7 13 
  
L1MC3 4 
  
L1MC4B 15 
  
L1MC5 1 
  
L1ME3C_3end 1 
  
L1ME3D_3end 3 
  
L1ME3E_3end 1 
  
L1ME5 1 
  
L1P_MA2 5 
 
L2 
 
9 
  
L2 8 
  
L2B 1 
 
RTE 
 
36 
  
BovB 36 
SINEs     225 
 
SINE 
 
24 
  
BCS 1 
  
BOVA2 23 
 
SINE2/tRNA 
 
189 
  
Bov-tA1 28 
  
Bov-tA2 10 
  
Bov-tA3 4 
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Table 3. Continued  
Class Superfamily  Family Frequency 
  
Bovc-tA2 11 
  
BOVTA 40 
  
BTALUL1 1 
  
CHR-2_BT 13 
  
CHR-2A 9 
  
CHR-2B 15 
  
CHRL 9 
  
CHRL1_BT 1 
  
MIR 11 
  
MIR3 3 
  
MIRb 13 
  
MIRc 5 
  
SINE2-1_BT 6 
  
SINE2-2_BT 8 
  
SINE2-3_BT 1 
  
THER1 1 
 
RTE 
 
12 
    
  
BTALUL2 12 
ERV     44 
 
ERV1 
 
15 
  
BtERVF2_I 1 
  
ERV1-2-I_BT 2 
  
LTR1_BT 6 
  
LTR11_BT 3 
  
LTR39B_BT 1 
  
LTR39D_BT 1 
  
MER41_BT 1 
 
ERV2 
 
1 
  
ERV2-1-
LTR_BT 1 
 
ERV3 
 
28 
  
LTR33C 1 
  
LTR67B 5 
  
MLT1E2 9 
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Table 3. Continued  
Class Superfamily  Family Frequency 
  
MLT1F 1 
  
MLT1F1 2 
  
MLT1J 2 
  
MLT1J1 1 
  
MLT1J2 3 
  
MLT1M 4 
LTR     3 
 
Gypsy 
 
3 
  
LTR88b 3 
DNA Transposon     8 
 
DNA transposon 
 
1 
  
X25_DNA 1 
 
hAT 
 
3 
  
Charlie13a 1 
  
MER91B 1 
  
UCON52 1 
 
Mariner/Tc1 
 
4 
  
MER47B 2 
  
TIGGER5_B 1 
    TIGGER5A 1 
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Figure 8. Repeat element analysis within bovine NK-lysin region. (A) Distribution of 
repeat classes within the assembled supercontig Bo-NK. Four junction points and genes 
are indicated. (B) Distribution of SINE elements within 5 Kb upstream and downstream 
of each junction point. The portion of each element relative to its consensus sequence is 
shown on the y axis. 
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Figure 9. Comparison of the repeat densities between whole genome assembly 
(UMD_3.1.1) and the assembled Bo-NK supercontig. 
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Discussion 
By sequencing the BAC clones, we provided evidence for tandem duplications of three 
NK-lysin genes, likely derived from an ancestral fourth copy located ~ 41.8 Kb 
downstream on cattle chromosome 11. Conserved features of NK-lysin orthologs exist in 
all four bovine NK-lysin genes, including the presence of five exons/four introns, six 
well-conserved cysteine residues, and a high proportion of positively charged amino 
acids. Also, the genome context flanking the bovine NK-lysin gene family demonstrated 
conserved syntenies with the granulysin region of human and most other mammalian 
genomes. The human granulysin gene maps to chromosome 2 centromeric to SFTPB and 
USP39 and telometric to ATOH8 and ST3GAL5. Similarly, the bovine NK-lysin gene 
family maps centromeric to SFTPB and USP39 and telometric to ATOH8 and ST3GAL5 
on chromosome 11. The conserved genome context implies that no major inter-
chromosomal genomic reorganization occurred in this region since the divergence of the 
ancestors of cattle and humans.  
 
The arrangement of NK2A, NK2B and NK2C as head to tail in tandem triplicate 
replicates is consistent with predominate duplication pattern observed in cattle and other 
mammals including mouse, rat and dog. This is in contrast to the archetypical 
organization of interspersed duplications in higher primates [131-136]. Segmental 
duplication (SD) with subsequent differentiation is the major mechanism of gene family 
expansion. Acting as the substrates of genome evolution, SD regions are also 
particularly unstable and hotspots of copy number variation (CNV) [88, 134, 135, 137, 
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138]. Further studies are necessary to test the copy number polymorphism of each NK-
lysin gene within this family. In order to characterize the mechanism of this gene family 
expansion, we investigated the features of sequences flanking each breakpoint, and 
found that the fragments downstream of each breakpoint were highly repetitive. These 
highly repetitive regions share high sequence homology and potentially drive 
rearrangements among the genetic elements flanked by these repeats, which can result in 
deletions or duplications of genomic fragments.    
 
In contrast to the single copy of NK-lysin gene in most species including human, pig, 
chicken and horse, four NK-lysin genes are clustered in a region with highly repetitive 
sequences in the cattle genome. Cattle are the first mammals in which multiple NK-lysin 
genes have been found, and this is consistent with the observation of gene family 
expansions in cattle for several other genes related to innate host immunity, such as the 
defensins, cathelicidins and interferons [139-142]. Perhaps reflecting an evolutionary 
strategy to deal with the substantial number of pathogens and the increased risk of 
infections in the rumen of cattle, the enlarged gene families encoding the antimicrobial 
peptides may be selected to meet an increased demand [143]. Further studies are needed 
to investigate the function of each NK-lysin gene.   
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CHAPTER III 
BIOLOGICAL FUNCTION OF BOVINE NK-LYSIN GENES 
*
 
 
Introduction 
A multi-gene family is a group of genes that arise from a common ancestral gene and 
share high sequence identity and some conserved features to each other. Three models 
have been proposed for the evolutionary process of a multi-gene family, “divergent 
evolution”, “concerted evolution” and “birth-and-death evolution”  [144]. The 
“divergent evolution” model proposes that duplicated genes diverge gradually from each 
other since the duplication event. While the ancestor gene keeps its original function, the 
duplicates are free from purifying selection and can accumulate mutations and 
eventually acquire new gene functions. In contrast to the divergence among gene family 
members from the “divergent evolution” model, members in a gene family could evolve 
in a concerted manner and share high sequence identity to each other due to the gene 
conversion events proposed by the “concerted evolution” model. Another model is the 
“birth-and-death evolution” model, in which some duplicated genes are functional and 
maintained in the genome for a long time, whereas others are deleted or become pseudo-
genes. Although four bovine NK-lysin genes are identified in the cattle genome and each 
has a complete genomic structure with five exons and four introns, their expression 
pattern and biological functions are unknown.  
                                                 
*
 Part of this chapter is reprinted with permission from “Bovine NK-lysin: Copy number variation and 
functional diversification” by Chen J, et al, 2015. Proc Natl Acad Sci U S A, 112(52):E7223-9, Copyright 
[2015] by the National Academy of Sciences of the United States of America. 
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Cationic AMP molecules can interact with both anionic phospholipid model membranes 
and bacterial membranes, presenting an unordered structure in lipid-free state while 
adopting a more helical structure upon binding to lipid membranes [145]. Circular 
dichroism (CD) spectroscopy is a valuable tool to study the conformational change of a 
peptide from lipid-free to lipid-bound states based on the differences in the far-UV (180-
260 nm) CD spectrum. CD is the dichroism resulting from the differential absorption of 
left and right circularly polarized light by an asymmetrical and optically active molecule, 
including peptides. Secondary structure of a peptide refers to the general three 
dimensional form of a local segment within the peptide, which is determined by the 
pattern of hydrogen bonds formed between amine hydrogen and carbonyl oxygen atoms 
contained in the backbone of peptide bonds. Common secondary structures include alpha 
helices, beta sheets, beta turn and random coils, and each structure presents a 
characteristic CD spectrum in the far-UV region. The fraction of each secondary 
structure in an unknown peptide can be estimated by comparing its CD spectrum to a set 
of reference molecules whose secondary structures have been previously determined by 
the high-resolution X-ray crystallography or nuclear magnetic resonance (NMR) 
spectroscopy. 
 
Cationic AMPs are proposed to kill targets by forming pores in the membranes. In this 
study, liposome leakage assay was performed to investigate the disruptive effects of 
bovine NK-lysin peptides on the model membranes mimicking bacterial membranes, and 
antimicrobial effects on cell membranes were further confirmed with transmission 
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electron microscopy (TEM). In the liposome leakage assay, large unilamellar vesicles 
(LUV) are prepared with entrapped fluorophore/quencher dyes. The fluorescence of the 
fluorophore is quenched by the quencher when the liposome is free from damage, 
resulting in the low detected fluorescence intensity. However, the detected fluorescence 
intensity is increased when the liposome is disrupted due to the leakage of entrapped 
fluorophore dye, which is free from the quenching influences of the quencher dyes. The 
detected fluorescence intensity is associated with the disruptive effects of peptides 
before the liposome is completely disrupted [146]. 
 
Materials and methods 
Expression profiles  
Total RNA was extracted from intestine Peyer’s patch (IPP), lung, thymus, spleen and 
respiratory lymph nodes (RLN) from three mixed breed cattle using the RNeasy Mini kit 
(Qiagen). RNA was then reverse transcribed into cDNA with a SuperScript® II Reverse 
Transcriptase kit (Invitrogen). Real-time PCR with Taqman-MGB chemistry was 
employed to study the expression pattern of each bovine NK-lysin gene in the prepared 
tissues. Specific Taqman-MGB probes for each of the NK1, NK2A and NK2C genes 
were designed using Primer Express v.2 software (Applied Biosystems) and the 
corresponding primer pairs were designed within 50 bp upstream and downstream from 
the probe using Primer3. The specificity of each probe was validated if the probe worked 
only for the plasmid containing its target gene template in a qPCR test reaction, but not 
for the plasmid containing other NK-lysin templates. As for the NK2B gene, no feasible 
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specific probe was achieved, and therefore a pair of gene-specific PCR primers was 
designed where 3’ end of both forward and reverse primers were placed at the gene 
specific loci. Specificity of NK2B primers was confirmed by sequencing fifteen clones 
from the cloned qPCR product. Primer Express v.2 was then utilized to search for a 
feasible Taqman-MGB probe within the NK2B amplicon. All primer and probe 
information is summarized in Table 4. Primers were synthesized by Sigma and Taqman-
MGB probes plus the bovine GAPDH gene expression master mix were purchased from 
Applied Biosystems. Quantitative PCR was performed in triplicate reactions with a 20 
µL mixture containing equivalent amount of cDNA from each tissue, 2 × Taqman 
Universal master mix (Applied Biosystems), 0.3 µM of each forward and reverse primer 
and 100 nM Taqman-MGB probe. The reaction was carried out following the program: 
50 ℃ for 2 min, 95 ℃ for 10 min, followed by 95 ℃ for 15 s and 60 ℃ for 1 min for 40 
cycles. The mean threshold cycle value (Ct) of each sample was normalized to the 
internal control, GAPDH, and the expression profile for each gene was obtained by 
comparing its normalized Ct value to the calibrator sample, where the gene exhibited the 
lowest expression level.  
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Table 4. Primer and probe information 
 
Primer  Forward (5' to 3') Reverse (5' to 3') Probe (5' to 3') 
Ex-
NK1 
CCAGCAAGAATGTC
ATCATCC 
GTCCTTAGAGATGCGAT
TGAGATAC 
CTTTGCAACCAG
ATGA 
Ex-
NK2A 
AGGAGAAGAGCTG
GGCCTAC 
GCTGATCTCCCAACTTG
TCC 
TCCTTGTTGGATG
ATAATG 
Ex-
NK2B 
GAGAATACCGTCAT
CGAGGC 
TTGCACAGACCTTTCAG
CG 
TCCAAGGTGTGC
GGC 
Ex-
NK2C 
AATTTCTCCGTACC
ATCGCT 
ATGAAACCTACTGGCTT
GCTT 
AGGACATCGTAG
CTGG 
 
Peptide synthesis 
Four 30-aa peptides corresponding to the functional region helices 2 and 3 of each NK-
lysin gene product were synthesized with > 95% purity by Peptide 2.0 Inc (Chantilly, 
VA). Amino acid compositions and properties of peptides are summarized in Table 5 
Lyophilized peptides were dissolved and aliquoted in 10 mM potassium phosphate 
buffer (pH 7.4) and stored at −20 °C before use. Concentrations of the stock peptides 
were determined by amino acid assay in the Texas A & M University Protein Chemistry 
Lab. 
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Table 5. Sequences and properties of four synthetic bovine NK-lysin peptides 
 
Pept
ide Sequence 
Length
(aa) 
Cha
rge 
Net Charge 
(pH 7) 
Hydrophobicity 
(pH 6.8) 
NK1 
VIIHVTSKVCSKMGLWSILC
NQMMKKYLNR 30 +6 4.93 37.1 
NK2
A 
TVIEVASKMCSKMRLLKGL
CKSITKRFLRR 30 +8 7.82 31.43 
NK2
B 
TVIEAASKVCGKMGPLKGL
CKSITKRFLRR 30 +7 6.82 26.1 
NK2
C 
TVIEEASKVCSKMRLLKGLC
KSIMKKFLRT 30 +6 5.82 30.57 
 
Circular dichroism (CD) assay  
Phospholipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE), 1-
palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (POPG) and 1',3'-bis[1,2-
dimyristoyl-sn-glycero-3-phospho]-sn-glycerol (Cardiolipin) were purchased from 
Avanti Polar Lipids (U.S.A.). Lyophilized lipids were dissolved in chloroform to a 
concentration of 20 mg/mL and stored at −20 °C before use. To prepare the negatively 
charged liposome containing 35% POPE, 50% POPG and 15% cardiolipin, the 
appropriate amounts of the lipid stock solutions were mixed and the chloroform was 
evaporated under N2 with constant rotation, so that the dried lipid mixture formed a thin 
film on the glass wall, which was further dried in a vacuum environment overnight. The 
dried mixture was re-suspended in potassium phosphate buffer (10 mM, pH 7.4) to the 
concentration of 10 mM, vortexed for ten mins, bath-sonicated for fifteen mins and 
subjected to five freeze-thaw cycles. The solution was subsequently extruded through a 
polycarbonate membrane (100 nm), back and forth, twenty times and stored at 4 °C 
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before use. The CD spectrum was obtained in the same phosphate buffer containing 20 
µM of each peptide with or without liposome at the working concentration of 1 mM at 
room temperature with a JASCO J-815 CD Spectrometer (JASCO, Easton, MD). Each 
sample was scanned five times at wavelengths ranging from 190 to 250 nm with the step 
resolution of 1 nm. All data were expressed as the mean molar ellipticity (deg.cm
2
.dmol
-
1
), background (buffer or liposome only) subtracted and the content of each secondary 
structure including alpha-helix, beta-sheet and beta-turn was estimated with the analysis 
software provided by the manufacturer of the CD spectrometer using CONTIN with 
SDP48 as the reference set.  
 
Liposome leakage assay (Fluorescence quenching assay)     
Liposome containing 35% POPE, 50% POPG and 15% cardiolipin and the entrapped 
fluorophore/quencher (ANTS/DPX) dye pair were prepared by a method similar to that 
described above, except that the potassium phosphate buffer was replaced by a dye-
containing Pipes buffer (5 mM ANTS/50 mM DPX/20 mM Pipes/27.5 mM NaCl, pH 
7.4) to suspend the dried lipids. The liposome with entrapped ANTS/DPX was subjected 
to a G-50 Sephadex chromatography column to eliminate the free dye, and the total lipid 
concentration of the collected dye-free fractions was determined by a phosphorus assay 
[147]. Dye-free liposome was mixed with or without peptides in a Pipes buffer (20 mM 
Pipes/ 85 mM NaCl, pH 7.4) to a final lipid concentration of 300 µM and peptides at a 
serial dilutions of 0.5, 1, 2, 5 and 10 µM. The fluorescence intensity was measured using 
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a BioTek Synergy 2 microplate reader, with excitation filter 330/80 and emission filter 
540/35. Fluorescence intensity was measured before and after the addition of peptides. 
 
Bacterial killing assay  
Overnight cultures of gram-positive S. aureus (ATCC 25923) and gram-negative E. coli 
(ATCC 25922) grown in lysogeny broth (LB) at 37℃ with aeration were sub-cultured to 
fresh LB at a ratio of 1:50 and grown at 37℃ with aeration for another 2.5 hours to mid-
exponential phase, washed and re-suspended in potassium phosphate buffer (10 mM, pH 
7.4) to a concentration of 3 × 10
6
 CFU/mL. An aliquot of 110 µL of prepared bacterial 
cells was incubated with 10 µL buffer or buffer plus peptides at working concentrations 
of 0.05, 0.1, 0.5, 1 µM at 37 ℃ for 2 h, and then plated onto LB agar plates. Colonies of 
the surviving bacteria were manually counted after overnight incubation at 37 ℃. The 
results were collected from four biological replicates and two independent experiments. 
 
Transmission electron microscopy (TEM) 
One hundred and ten µL of the E.coli cells (ATCC 25922) (3 × 10
8
 CFU/mL) were 
incubated with 10 µL buffer or buffer plus 5 µM NK1 peptide at 37 ℃ for 20 mins. Cells 
were fixed with equal volume of 2.5 % glutaraldehyde at room temperature for 2 hours, 
washed and placed in 0.1 M sodium cacodylate buffer. The fixed cells were postfixed in 
1% OsO4 with 1% K4[Fe(CN)6] for 1 hour at 4 ℃, rinsed with 0.1 M sodium cacodylate 
buffer, followed by dehydration in an ascending ethanol gradient ( 50%, 70%, 80%, 
90%, 95% and 100%) and embedded in epoxy resin. Ultrathin sections were obtained 
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with a Leica EM UC6 ultramicrotome and poststained with uranyl acetate and lead 
citrate, and examined with a Morgagni 268 transmission electron microscope (FEI). 
Additional image analyses were performed with ImageJ [148]. Statistical analysis of the 
mean electron intensities of thirty cells from both the control and NK1-treated groups 
was performed with student t-test (paired, two-tailed, unequal variances).  
 
Results 
Tissue expression of the bovine NK-lysin genes   
To test whether all the identified bovine NK-lysin genes are expressed and display the 
same expression profile, we compared the mRNA levels of each gene among five 
tissues, including lung, thymus, spleen, respiratory lymph node (RLN) and intestine 
Peyer’s patch (IPP). Real time PCR analysis demonstrated that all four bovine NK-lysin 
genes are expressed but each exhibits a tissue specific expression profile (Fig. 10). NK1 
and NK2A genes are highly expressed in the IPP, but expressed at extremely low level in 
the lung. The difference was greater than 100-fold. NK2B is more generally expressed 
with highest levels in the IPP and lung. A distinct expression pattern was observed for 
NK2C, where it was expressed at the highest level in the lung, indicating a potential 
novel function. 
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Figure 10. Expression of four bovine NK-lysins in lung (L), thymus (T), spleen (S), 
respiratory lymph node (RLN) and intestinal Peyer’s patch (IPP). The expression of each 
gene in the tissue that exhibited the lowest expression level was set at 1. The average 
expression levels and standard deviations were calculated from three healthy individuals.   
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Conformational changes of bovine NK-lysin peptides upon liposome binding   
To determine the interactions between bovine NK-lysin peptides and bio-membranes in 
target microorganisms, we employed circular dichroism (CD) spectroscopy to study the 
potential conformational changes of these peptides upon their interaction with anionic 
liposome mimicking bacterial membranes. The CD spectrum of each of the peptides in 
buffer presented a single negative band at 200 nm, which indicated an unordered 
structure (random coil) (Fig. 11A). However, two negative bands at 208 nm and 222 nm 
along with a positive band at 192 nm were exhibited when mixed with the negatively 
charged liposome (35% POPE + 50% POPG + 15% Cardiolipin), suggesting the 
conformational transition of the peptides from random coils to a more ordered structure 
(Fig. 11B). The proportional contents of the alpha–helix, beta-sheet and beta-turn of 
each peptide in both lipid-free and lipid-bound states were also compared (Fig. 11C,D). 
The proportions of the total ordered secondary structures, especially the alpha helices, 
were enhanced in the presence of liposome for all peptides. The fractions of each 
secondary structure for NK2A, NK2B and NK2C were comparable upon interaction with 
liposome, while those for NK1 were different with a lower degree of helicity and a 
higher proportion of beta-sheet in the lipid-bound state. This result was consistent with 
the behavior of most cationic AMPs, which exhibit an unordered structure in aqueous 
solution but adopt a more helical conformation upon interaction with anionic 
phospholipid membranes [149]. 
 
 
 51 
 
 
 
 
 
 
 
Figure 11.  Secondary structural changes of four synthetic bovine NK-lysin peptides 
upon liposome binding. CD spectra of NK-lysin peptides in lipid-free (A) and lipid-
bound states (B) are compared. Estimated secondary structural contents, including alpha-
helices, beta-sheet, beta-turn and the total secondary structure in lipid-free and lipid-
bound states are shown in (C) and (D), respectively. 
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Bovine NK-lysin peptides disrupt model membranes  
A liposome leakage assay was performed to investigate the influences of the synthetic 
bovine NK-lysin peptides on a model membrane. The peptides began to disrupt the 
liposome at a concentration of 0.5 µM, resulting in the release of entrapped fluorescence 
dye ANTS (Fig. 12). As the concentrations were increased to 1 µM and subsequently to 
2 µM, the released fluorescence intensities were correspondingly elevated and the 
leakage of entrapped dye caused by NK1 peptide was remarkably greater than that 
caused by the other peptides. However, the detected fluorescence intensity for the four 
peptides was comparable at the peptide concentration of 5 µM, and was maintained at 
this level when the concentration was increased to 10 µM, indicating the complete 
disruption of the vesicles at a peptide concentration of 5 µM.  
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Figure 12. Intensities of the released fluorescent dye (ANTS) from liposome plotted 
against the concentration of four bovine NK-lysin peptides.   
 
 
 
 
 54 
 
Bovine NK-lysin peptides exhibit antimicrobial effects on both Gram-positive and Gram-
negative bacteria   
Antimicrobial capacities of the synthetic forms of four bovine NK-lysin peptides were 
tested against both the gram-positive bacteria S. aureus and the gram-negative bacteria 
E. coli. All peptides were effective against both bacterial strains at nanomolar 
concentrations, although gram-negative E. coli was more susceptible (Fig. 13A). At the 
lowest peptide concentration of 0.05 μM, an approximately 10-fold decrease in viable 
E.coli cells was observed, and bacterial numbers were reduced from initial 10
6
 CFU/mL 
to less than 10
4
 CFU/mL after incubating with 1 μM of NK2A, NK2B or NK2C 
molecules for 2 hr. Even fewer cells (400 CFU/mL) survived incubation with 1 μM NK1 
peptide. All peptides were less active against the gram-positive S. aureus (Fig. 13B). 
Bacterial numbers were not significantly reduced when incubated at peptide 
concentrations up to 0.1 μM for any of the four peptides. At 0.5 μM, all peptides 
produced approximately 10-fold cell loss. At the concentration of 1 μM, the NK1 
molecule reduced S. aureus numbers by approximately 100-fold, which was stronger 
than the other three peptides. Although there was a difference in the ability of the 
peptides to kill gram-positive and gram-negative bacterial strains, the NK1 peptide 
showed strongest antimicrobial effects against both strains.  
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              A                                                            B 
 
 
 
Figure 13. Antimicrobial activities of four bovine NK-lysin peptides against gram-
negative E. coli (A) and gram-positive S. aureus (B). Cell viabilities were analyzed by 
comparing the surviving cells after peptide treatment with the control. Error bars 
represented the standard deviations calculated from four biological replications. 
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Synthetic NK1 peptide disrupted the E. coli membrane  
The effects of bovine NK-lysin molecules on the E. coli cell membrane were investigated 
by transmission electron microscopy (TEM) (Fig. 14). Specifically, the membrane 
integrity and intracellular structure were compared and analyzed between untreated 
E.coli cells and cells treated with 5 μM NK1 peptide. Most of the untreated cells 
maintained a normal cell shape with an intact cytoplasmic membrane and full 
cytoplasmic contents (Fig. 14A), whereas treated cells had characteristic expansion of 
the periplasmic space with shrinkage of the cytoplasmic compartment (Fig. 14B). The 
cytoplasm of treated cells was less electron dense with clear zones, indicating the 
disruption of the cell membranes and leakage of intracellular contents. Protruding 
bubbles were observed from the membrane of treated cells (Fig. 14D) whereas outer 
membranes of untreated cells displayed a uniform appearance with slightly waved 
membranes (Fig. 14C). Statistical analysis confirmed that the average electron density of 
untreated cells was significantly (P < 0.001) stronger than the treated ones (Fig. 14E). 
The results from this assay demonstrated the lytic action of bovine NK-lysin peptides, 
which may directly cause pore formation in the cell membrane.  
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Figure 14. Transmission electron micrographs of E.coli cells with and without 5 uM 
NK1 peptide treatment. (A)(C) Control cells. (B)(D) Cells treated with 5 uM NK1 
peptide for 20 mins. (E) Comparison of the average electron intensities of thirty cells 
between the control and NK1-treated cell groups. 
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Discussion 
During the evolution of a gene family, it is common for the ancestor gene copy to 
maintain its original biological function while the duplicates can accumulate mutations 
and potentially evolve into genes with novel functions. For example, duplicates of 
bovine lysozyme genes, an immunity-related gene family, exhibit non-immune functions 
in the digestive systems [143]. In this study, gene expression profiles showed that three 
bovine NK-lysin genes NK1, NK2A and NK2B are predominately expressed in the 
intestine Peyer’s patch which is consistent with the NK-lysin orthologs in most other 
species, while the bovine NK2C gene is expressed at the highest level in lung, indicating 
its potential novel function in the bovine respiratory system. It will be interesting to 
measure the expression of each bovine NK-lysin gene in more tissue types to investigate 
their potential novel functions, including rumen, stomach, liver, heart, brain, muscle and 
kidney. 
 
Cationic AMPs are important molecules in the innate immune system and are 
widespread in both plant and animal kingdoms [14]. One of the conserved characteristics 
of AMPs is their cationic and hydrophobic composition, which enables them to be potent 
killers of microbes with cytoplasmic membranes rich in anionic phospholipids and 
selectively safe to host cells with neutral charged membranes. Several factors are 
proposed to affect the antimicrobial capacities of AMPs, including the net positive 
charge, hydrophobicity and amphipathicity. Increased positive charge and 
hydrophobicity are two major contributors to the enhancement of the antimicrobial effect 
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of an AMP molecule [150, 151]. The net charges (pH = 7) and hydrophobicities (pH = 
6.8) differ among the functional regions of the four examined NK-lysin peptides, with 
NK1 possessing the highest hydrophobicity with the least positive charge and NK2A 
being the most positively charged peptide (Table 5). During gene family expansion, each 
paralog has evolved to encode a peptide with a specific amino acid composition, which 
might enable the bovine NK-lysin family to be active against a broad range of microbes. 
Although NK1 peptide showed the strongest killing ability against both E. coli and S. 
aureus cells, other NK-lysin peptides may exhibit stronger effects on different targets. 
Further studies are therefore suggested to compare the antimicrobial activities of each 
NK-lysin peptide against more bacterial strains. 
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CHAPTER IV 
RESPONSE OF BOVINE NK-LYSINS TO BRD-ASSOCIATED PATHOGENS 
 
Introduction 
Bovine respiratory disease (BRD) or shipping fever is the most common infectious 
disease affecting both the upper and lower respiratory tracts of cattle and is a major 
cause of economic loss in North America through treatment costs, reduced performance 
and mortality [152-154]. BRD is multi-factorial with a variety of stressors, including 
host factors (age, genetics and host immunity) [155-157], environmental factors 
(temperature, transport, commingling and ventilation) [158-160] and pathogens (bacteria 
and viruses) leading to disease. Several microorganisms have been implicated in the 
pathogenesis of BRD including bacterial agents, such as Mannheimia haemolytica [161, 
162], Pasteurella multocida [161], Mycoplasma bovis [163] and Histophilus somni 
[164], and viral agents, such as bovine viral diarrhea virus (BVDV) [163], bovine 
respiratory syncytial virus (BRSV) [165], bovine herpesvirus-1 (BHV-1 or IBR) [165] 
and bovine parainfluenza-3 virus (PI-3) [166]. Interactions between environmental 
stressors and infectious agents are critical to the development of BRD. Environmental 
factors (such as transport or weaning) weaken the host’s immune system and predispose 
animals to viral infections, which then precipitate secondary infections by bacterial 
pathogen, leading to the onset of BRD. Many efforts have been made to prevent and 
treat BRD, including feedlot management to reduce environmental stresses, vaccination 
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of animals to improve immune responses, breeding of cattle that are resistant to BRD 
pathogens [167] and anti-infectious agents (antibiotics and sulfas) to treat infected cattle. 
 
RNA sequencing (RNA-seq), also called whole transcriptome shotgun sequencing 
(WTSS), is a powerful technology in which RNA is reverse transcribed into cDNA, 
which is then sequenced by the next-generation sequencing technology. RNA-seq allows 
scientists to profile the transcriptome of any tissues at any developmental stage. Since its 
inception, RNA-seq has been under active development and applied to many studies 
related to gene expression, mainly due to its advantages over other existing technologies 
such as microarrays [168]. The first advantage of RNA-seq is its unbiased detection of 
novel transcripts. Unlike the microarray technology which limits researchers to 
transcripts that correspond to existing genomic sequences, RNA-seq does not require 
transcript-specific probes and therefore can explore novel transcripts and enable 
transcriptome profiling for non-model organisms. Variations such as SNPs, INDELs and 
other previously unknown changes can also be detected by RNA-seq through 
transcriptome comparisons among different individuals. The second advantage of RNA-
seq over microarrays is its low background signal, because sequencing reads can be 
unambiguously mapped to unique regions of the genome. Thirdly, RNA-seq can 
quantify a broad range of expression levels by analyzing the number of sequencing reads, 
which makes it feasible to detect low-abundance transcripts. RNA-seq can also deliver 
increased specificity and sensitivity in quantifying gene expression with strict 
parameters set for the analysis when compared to microarrays. Since four bovine NK-
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lysin genes share high sequence identity to each other, RNA-seq analysis becomes a 
valuable method to compare the expression of each NK-lysin gene among healthy 
animals and animals challenged with pathogens associated with bovine respiratory 
diseases.  
 
Materials and methods 
RNA-seq data analysis 
RNA-seq data were generated and analyzed at the University of Missouri. Computations 
were performed on the HPC resources at the University of Missouri Bioinformatics 
Consortium (UMBC). Animal challenge and whole transcriptome sequencing protocols 
were previously described [169] [170]. In this study, we analyzed the bovine NK-lysin 
expression in both the lung lesion and bronchial lymph node tissues [169, 170] collected 
from the same individual. Since the four bovine NK-lysins share high sequence identity, 
especially NK2A, NK2B and NK2C, protocols were designed with extra care to remap 
the short (2 x 50 bp) reads specifically to each gene. Basically, all short reads from each 
sample were mapped with no allowed mismatches to a bowtie index built with the 
mRNA sequences of all four NK-lysins using Bowtie 2 [171]. The mapping quality 
which measures the degree of confidence in mapping a read to a specific single locus 
was used to assess whether the reads were uniquely mapped to one of the four genes, and 
the number of these uniquely mapped reads was counted for each NK-lysin gene. Quality 
trimmed reads with a size of < 25 bp were excluded from this analysis.  
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Antimicrobial killing assay 
Overnight cultures of four pathogenic bacterial strains (P. multocida ATCC 43019, 
ATCC 43137 and M. haemolytica ATCC BAA-410, ATCC 33396) were sub-cultured in 
brain-heart infusion (BHI) medium at 37 ℃ for an additional 2.5 hours to mid-
exponential phase, washed and re-suspended in PBS (pH 7.4) to a cell concentration of 5 
× 10
6
 CFU/mL. A 100-µL aliquot of cells was incubated with 20 µL PBS buffer or 
buffer plus each NK-lysin peptide prepared in the same buffer to the final peptide 
working concentrations of 1, 2, 5 and 10 µM at 37 ℃ for 1 h. After the 1 h incubation, a 
100-µL aliquot of each mixture was diluted in PBS buffer to an approximate cell 
concentration of 3 × 10
3
 CFU/mL, from which another 100-µL aliquot was plated on 
Trypticase soy agar plates with 5% sheep blood. Colonies of the surviving cells were 
manually counted after overnight incubation at 37 ℃. Experiments were performed with 
four biological replicates.  
 
Transmission electron microscopy (TEM) 
50-µL overnight culture of Pasteurella multocida ATCC 43019 was sub-cultured in 5 
mL BHI medium for 2 h. Four mL of the cell culture was subsequently washed and re-
suspended into PBS buffer, and incubated with 20 µM NK1 peptide or an equal volume 
of PBS buffer for 30 mins at 37 ℃. The mixture was fixed with an equal volume of 3% 
glutaraldehyde and samples for TEM examination were prepared following the 
previously described protocol in CHAPTER III.  
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Results 
Elevated expression of bovine NK2C in animals challenged with BRD pathogens    
In this study, we investigated the potential contributions of bovine NK-lysins to host 
resistance to BRD pathogens, especially the NK2C gene which is expressed in lung at a 
high level. The expression level of each NK-lysin gene was represented as the Fragments 
per Kilobase of transcript per Million (FPKM) value and compared in bronchial lymph 
node and lung lesion tissues among healthy animals and animals challenged with a set of 
BRD-causing pathogens. Overall, the expression of NK1 gene was very low in these 
tissues while NK2C exhibited relatively high expression in both tissues (Fig. 15). When 
animals were challenged with the IBR virus, the expression of NK2A, NK2B and NK2C 
was significantly elevated in bronchial lymph nodes, and an increased expression of 
NK2B and NK2C in bronchial lymph nodes was also observed in most of the animals 
challenged with other pathogens (Fig. 15A). An elevated expression of NK2A and NK2C 
in lung was also observed in most of the pathogen-challenged animals, and the 
expression of NK2C was significantly higher than for the other three genes in the lungs 
(Fig. 15B). In contrast to the comparable gene expression levels in the four healthy 
control animals, the expression of NK2C showed large variation among animals within 
the same challenged group and the expression was elevated by > 20-fold in some of the 
experimentally challenged animals. All of these results suggest that NK2C can 
potentially play a significant role in host defense against specific infectious agents 
involved in BRD.  
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Figure 15. Comparisons of the expressions of four bovine NK-lysin genes in bronchial 
lymph node (BLN, A) and lung (LNG, B) among healthy animals and animals 
challenged with P.multocida, M.bovis, M.haemolytica, BRSV, BVDV and IBR. The Y 
axis shows the FPKM value, and each black dot represents the FPKM value of an 
individual. Three or four individuals were included in each control and challenged 
group. 
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Bovine NK-lysin peptides exhibit antimicrobial effects on BRD-causing bacteria P. 
multocida and M. haemolytica   
The antimicrobial activities of bovine NK-lysin peptides were tested against two P. 
multocida bacterial strains (ATCC 43019 and ATCC 43137) and two M. haemolytica 
bacterial strains (ATCC BAA-410 and ATCC 33396). Overall, the P. multocida strains 
were less susceptible to the peptides than the M. haemolytica strains (Fig. 16 A, B). 
Significant cell number losses were not observed until the peptide concentration was 
increased to 10 µM for NK1 and NK2A when an approximately 50-fold decrease in 
viable cells was produced. The NK2B and NK2C peptides did not display obvious killing 
abilities against both P. multocida strains. In contrast, the NK2A and NK2C peptides 
displayed potent antimicrobial activities against both M. haemolytica strains in a dose-
dependent manner (Fig. 16 C, D). An approximately 5-fold decrease in cell numbers 
resulted from incubation with 1 µM of NK2A for 1 h, and the complete elimination of M. 
haemolytica cells was achieved with 5 µM of NK2A or 10 µM of NK2C. NK1 and NK2B 
peptides exhibited weaker killing abilities against M. haemolytica and achieved an 
approximately 50-fold cell loss at the highest concentration of 10 µM. Surprisingly, M. 
haemolytica cells were very susceptible to the NK2A peptide but resistant to the NK1, 
which was the most potent peptide against P. multocida as well as E. coli and S. aureus 
in our previous study.  
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Figure 16. Antimicrobial effects of bovine NK-lysin peptides on BRD-causing 
pathogens P. multocida strains ATCC 43019 (A) and ATCC 43137 (B), M. haemolytica 
ATCC BAA-410 (C)  and ATCC 33396 (D). Surviving cell numbers after peptide 
treatment are shown on the Y axis. Error bars represent the standard deviations 
calculated from four biological replications. 
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Bovine NK1 peptide lyses Pasteurella multocida cell membranes   
The impacts of bovine NK-lysin peptides on the cell morphology and membrane 
integrity of Pasteurella multocida cells were examined by transmission electron 
microscopy (TEM) (Fig. 17). The untreated cells displayed intact outer and inner 
membranes with a clear periplasmic space, and the cytoplasm was homogeneously filled 
with electron dense material (Fig. 17A). Although the cell morphology was maintained, 
severe cellular damage with large clear zones in the cytoplasm indicating the leakage of 
cytoplasmic contents was observed when cells were treated with 20 µM of NK1 peptide 
for 30 mins (Fig. 17B). In addition, cytoplasmic constituents were coagulated into non-
membrane-enclosed bodies within the areas near membranes. NK1 peptide treatment 
also caused the breakage of cell membranes (Fig. 17C arrows a & b) and the formation 
of protruded bodies in the cell membrane, resulting in the leakage of cytoplasm (Fig. 
17C arrows c & d). Statistical analysis revealed that the overall electron density of an 
untreated P. multocida cell was significantly higher than that of a cell treated with 
bovine NK1 peptide for 30 mins, suggesting the leakage of cytoplasmic contents in 
NK1-treated cells (Fig. 17D). Therefore, bovine NK1 peptide can cause the release of 
cytoplasmic material from a P. multocida cell by damaging its cell membrane, which 
will eventually lead to cell death and the appearance of empty “shells” (ghost cells).  
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Figure 17. Influence of 20 µM of bovine NK1 peptide on the cell membrane of 
Pasteurella multocida (ATCC 43019) examined by transmission electron microscopy. 
(A) Control cells. (B) and (C) Cells treated with 20 µM NK1 peptide for 30 mins. (D) 
Statistical analysis of the average electron intensity of control cells versus NK1-treated 
cells. Thirty cells from each group were used for statistical analysis.   
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Discussion 
As discussed in the CHAPTER III, the synthetic NK1 peptide possesses the highest 
hydrophobicity and largest hydrophobic face with the least positive charge and NK2A is 
the most positively charged peptide (Fig. 18), which might enable the bovine NK-lysin 
family to be active against a broad range of microbes. Bacterial killing results revealed 
that NK1 exhibited the strongest antimicrobial effects on E. coli, S. aureus and P. 
multocida cells while NK2A was the most potent peptide against M. haemolytica, further 
demonstrating that each NK-lysin paralog has evolved to encode a peptide with a 
specific property and thus specific targets. The whole NK-lysin gene family cooperate 
together to enhance the host resistance to a wide range of infectious microbes. 
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(A) 
 
                          
Figure 18. Helical wheel of four synthetic bovine NK-lysin peptides: (A) NK1, (B) 
NK2A, (C) NK2B and (D) NK2C. Hydrophilic residues (circles), hydrophobic residues 
(diamonds), negatively charged residues (triangles) and positively charged residues 
(pentagons) are indicated. Color indicates the hydrophobicity of a residue, in which 
green represents the most hydrophobic residue, and the amount of green is decreasing 
proportionally to the hydrophobicity with yellow representing zero hydrophobicity. 
Hydrophilic residues are coded red with pure red being the most hydrophilic residue, and 
the amount of red decreasing proportionally to the hydrophilicity. Light blue indicates 
the potentially charged amino acids. 
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Figure 18 Continued 
 
(B) 
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Figure 18 Continued 
 
 (C) 
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 Figure 18 Continued 
 
(D) 
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Identification of genes that influence the host response to BRD pathogens is an 
important step towards identifying the specific genetic variants which could be used in 
breeding cattle with an increased resistance to infections. Several studies have been 
undertaken to search for genes and associated genetic variants that contribute to host 
resistance to BRD pathogens or responses to vaccines, and the proposed genes or 
genomic regions include the MHC region, TLRs, PVRL1 and DST [167, 172]. With the 
application of high density SNP genotyping technology, genome wide association 
studies become a valuable method for identifying genetic markers linked to phenotypic 
variation in BRD signs [167, 173, 174]. Another effective approach to the identification 
of genetic variants that could be beneficial to animal breeding relies on the identification 
of polymorphisms within suggested candidate genes based on the biological functions of 
their gene products. Since innate immunity is not only an essential component of the 
host immune response but also affects subsequent acquired immunity, genes that are 
expressed in the innate immune system are strong candidates for their effects on host 
resistance to infectious agents. Human granulysin/NK-lysin is an effector molecule in 
the innate immune system, and its expression is inducible by antigenic stimulation 
indicating its potential role in host responses to antigens [64]. Despite the existence of 
large individual variation in expression within individuals challenged with the same 
BRD-associated pathogen, the expression of bovine NK-lysin genes, especially NK2C, in 
both the bronchial lymph node and lung were elevated in most of the challenged 
animals. The synthetic peptides corresponding to the functional helices 2 and 3 of each 
gene product exhibited antimicrobial effects on the BRD-associated bacterial microbes, 
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P. multocida and M. haemolytica, and antimycobacterial activity has also been 
previously reported with some other derived bovine NK-lysin peptides [83]. All of these 
findings suggest that the bovine NK-lysins are potentially important in host resistance to 
BRD infections.  
 
The large animal-to-animal variation within animals challenged with the same pathogen 
in the challenge study may be attributed to individual immunity, which at least partly 
results from genetic variation, such as gene copy number variations (CNVs), SNPs and 
INDELs. It will be important to investigate genetic variations within members of the 
bovine NK-lysin gene family and their regulatory regions to identify potential 
associations with host disease phenotypes. Further studies are therefore suggested to 
investigate the extent of copy number variation within and between breeds of cattle in all 
four bovine NK-lysins as well as the extent of nonsynonymous substitutions, especially 
in the region coding for the functional helices 2 and 3. Genotype-to-phenotype 
association studies could then be performed to test the effects of the identified genetic 
variants on host resistance to infectious agents, providing functional genetic makers for 
use in cattle breeding.  
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CHAPTER V 
GENETIC VARIATION WITHIN THE BOVINE NK-LYSIN REGION 
 
Introduction 
A large number of proteins are synthesized as precursors in the form of pre-pro-proteins. 
The “pre-” prefix indicates a signal peptide at the N-terminal region of a precursor that 
transports the precursor into the appropriate secretory pathway and then is cleaved from 
the precursor. Proteins with signal peptides are defined as pre-proteins. However, some 
precursors require additional processing to become fully active, including the cleavage 
of another peptide termed as the pro-region. Pro-regions can be N-terminal extensions, 
C-terminal extensions or a combination of both, but N-terminal extensions are the most 
common. Precursors with both signal peptides and pro-regions are defined as the pre-
pro-proteins. Pro-regions exist as a part of many pro-proteins, including α-lytic protease 
[175], subtilisin [176], carboxypeptidase Y (CPY) [177] and alkaline extracellular 
protease [178], and is required for the folding and maturation of the protein. Protein 
folding is considered as a competition process between the forward folding reaction and 
the reversed aggregation reaction, and the pro-region can facilitate the protein folding by 
either increasing the rate of forward reaction or decreasing the rate of aggregation 
reaction. Pro-regions are also involved in the intracellular protein transporting. Pro-
region of the CPY protease, for example, has been shown to be responsible for targeting 
the protein to the yeast vacuole [179]. In addition, pro-region can be a potent inhibitor of 
its associated mature protein and regulate the protein activities in the host. For example, 
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pro-CPY has less than 0.1% of the biological activity of its mature CPY [179]. It is 
possible that pro-regions play other unidentified important roles, and variation within 
this region could have significant influences on protein functions. Pig NK-lysin 
precursor (UniProtKB: Q29075) consists of 129 amino acids, where the first six residues 
comprise the signal peptide and residues 47 – 124 are processed to be the mature peptide 
while the rest of the residues (7 – 46 and 125 – 129) form the N- and C-terminal pro-
regions. Sequences of four bovine NK-lysin peptides were aligned with the pig NK-lysin 
to predict the peptide structure of the bovine NK-lysins (Fig. 19). The first twenty-two 
amino acids of bovine NK1 were predicted to comprise the signal peptide and residues 
63 – 140 formed the mature peptide while the pro-regions were made up of 23 – 62 and 
141 – 145 residues.  
 
 
 
 
Figure 19. Sequence comparisons of four bovine NK-lysin peptides (NK1, NK2A – C) 
with pig NK-lysin (Pig-NKL). The four bovine NK-lysin peptide sequences were 
predicted from the genomic sequence of L1 Domino 99375, donor for the CHORI-240 
Bovine BAC Library and PacBio sequencing. Red color indicates alignment with high 
consensus and blue represents alignment with low consensus. 
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Concerted evolution is a common pattern during the development of multigene families 
and explains the higher sequence identity shared by the paralogous genes within one 
species when compared to the ortholog in another species, even though the gene 
duplication event preceded the speciation event. One of the main proposed mechanisms 
responsible for the concerted evolution is gene conversion, which is involved in the 
genetic exchange, especially the unidirectional transfer of a fragment of sequence from a 
“donor” gene to the homologous “acceptor” gene, therefore converting the “acceptor” 
sequence [180].  The size of a gene fragment involved in a gene conversion event is 
variable, with some entire genes undergoing gene conversions and others displaying a 
mosaic evolution pattern. Under the mosaic evolution, some segments of the duplicated 
genes are homogenized by gene conversions while the rest of the gene sequences diverge 
with time, which usually complicates phylogenetic reconstructions and underestimates 
the evolution time [181-183]. There are four main methodologies to detect a gene 
conversion event [184], including the incompatibility between an estimated gene tree 
and the true duplication history, incompatibility of gene trees in different subregions, 
traces in the sequence alignment after gene conversion events and shared polymorphisms. 
Parallel mutations can create shared polymorphisms, but the probability that point 
mutations occur at the same locations of different duplicate genes is very low. Therefore, 
examination of shared polymorphisms is a powerful method to detect gene conversion 
events at the multisite variations (MSVs) [185-187]. MSV is a type of variation that 
refers to the polymorphism in paralogous genes within a gene family [188], including 
the MSV 1 and MSV 2, and is usually used to detect gene conversion sites. A SNP in 
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one of the duplicate genes and also a paralogous sequence variant is defined as a MSV 1, 
and a MSV 2 is a SNP shared by several duplicated genes [189]. A minimum gene 
conversion tract is a segment within an acceptor gene that spans at least two SNPs for 
which a potential donor gene could be identified. A maximum gene conversion tract is a 
segment that includes the minimum gene conversion tract plus the identical sequence 
between the donor and acceptor genes on both sides of the minimum gene conversion 
tract.   
 
Materials and methods 
Deletion of a 9-bp fragment in the third exon of NK1 
Two annotated mRNA sequences of bovine NK1 from the National Center for 
Biotechnology Information (NCBI) nucleotide database were aligned with the NK1 
mRNA sequence predicted from PacBio sequencing result using the Multiple sequence 
alignment by Florence Corpet (http://multalin.toulouse.inra.fr/multalin/). Total RNA was 
extracted from intestine Peyer’s patch (IPP) of four mixed breed cattle using the RNeasy 
Mini kit (Qiagen). RNA was then reverse transcribed into cDNA with a SuperScript® II 
Reverse Transcriptase kit (Invitrogen). A pair of primers (NK1-CDS) was designed to 
amplify the whole coding region of the NK1 gene using Primer3 
(http://bioinfo.ut.ee/primer3-0.4.0/) (Table 6). The prepared IPP cDNA from four 
different individuals were amplified by the NK1-CDS primers and the amplicons were 
sequenced at the DNA Technologies Core Lab (Texas A&M University). To identify the 
genomic location of the 9-bp INDEL, another pair of primers (NK1-9bp) spanning the 
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exon 2 – intron 2 – exon 3 region of NK1 were tested in the genomic DNA of nine 
individuals from different breeds (Table 7), and the sequences of amplicons were 
achieved by Sanger sequencing and analyzed with Multiple sequence alignment by 
Florence Corpet.  
 
Copy number variation of NK2B in Holstein cattle homozygous for the NK-lysin region 
Primer 3 was utilized to design a pair of primers (Bo-lysin) within the conserved region 
of NK2A, NK2B and NK2C genes, and PLINK was performed to identify individuals 
homozygous for all SNP sites across the entire NK-lysin region based on genotyping 
with the bovine 770K HD SNP array [167]. Genomic DNA from four homozygous 
Holstein cattle with different haplotypes was prepared for further analysis. Briefly, the 
Bo-lysin amplicons from each of the four selected cattle were cloned into the pCR™4 
Blunt-TOPO® vector (Life technologies), and the clones were prepared for sequencing 
at Beckman Coulter Genomics (Danvers, MA, U.S.A). Only sequences present at least 
three times among the clones from a single individual were used for analysis. All 
sequences were analyzed phylogenetically with the corresponding reference sequences 
of NK1 and NK2A-C by MEGA 6.0 [190], pig and horse NK-lysin sequences were 
included as outgroups. The absence of NK2B in individuals 2822 and 3850 were further 
confirmed by PCR with NK2B specific primers (Gs-NK2B).The same Gs-NK2B primers 
were also tested in individuals with different genotypes at the SNP 
(BovineHD1100014441, T/C) to determine the linkage of NK2B with this SNP.  
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Analysis of gene conversions within bovine NK-lysin gene family 
Genomic sequences of bovine NK2A, NK2B and NK2C were aligned using the Multiple 
sequence alignment by Florence Corpet. A specific pair of primers was designed for 
each NK2 gene (Gs-NK2A – C) by locating the 3’ end of primers at the mismatched 
nucleotide loci, and the specificity of primers were confirmed in the genomic DNA of 
L1 Domino 99375 which contains single copies of each NK2 gene. Genomic DNA of 
individuals from different breeds was amplified by the specific primers and amplicons 
were sequenced with Sanger sequencing at the DNA Technologies Core Lab (Texas 
A&M University). Sequences of all amplicons obtained by the same pair of primers 
were aligned to the NK2A, NK2B and NK2C sequences from L1 Domino 99375 using 
the Multiple sequence alignment by Florence Corpet.   
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Table 6. Primer and amplicon information 
 
Prim
er Forward (5' to 3') Reverse (5' to 3') 
Amplico
n    size Utilization 
NK1
-
CDS 
ATGACCTCTTG
GGCTGTTCT 
CAGATGGCCTG
AGGTGTCTT 395 bp 
NK1 coding region 
amplification  
 
NK1
-9bp 
TGACTTCTCCTC
TCCCTCTGTC 
AGGGAATTCTC
CAAAGTCCATT 873 bp 
Identification of genomic 
region of 9-bp INDEL   
 
Bo-
lysin  
ACCCAGCACTC
CCACTG 
ACATACCTGGC
TTGCTTTTG 293 bp Homozygotes analysis  
 
Gs-
NK2
A 
TGGTCCTTGTTG
GATGATAATG 
TTTCCAGCTGTG
ATGTCTGC 893 bp Gene conversion test 
 
Gs-
NK2
B 
CTGTTCATGCT
GTTTCTTCCAT  
TTGCACAGACC
TTTCAGCG 1479 bp 
 
NK2B deletion test 
 Gene conversion test 
 
Gs-
NK2
C 
CTACGCTGTGG
TTCTTGTCG 
GTTTTTCCAGCT
ACGATGTCCT 891 bp Gene conversion test 
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Table 7. Individuals used in the genetic study of bovine NK-lysin gene family 
 
Individual Breed Utilization 
9-bp 
INDEL 
SNP 
(BovineHD1100014441) NK2B 
Domino Hereford 
 
- /- 
  
23 Brahman 
9-bp INDEL 
test +/+ 
  
26 Brahman 
9-bp INDEL 
test +/+ 
  
43 Charolais 
9-bp INDEL 
test +/+ 
  
44 Charolais 
9-bp INDEL 
test +/+ 
  
70 Gelbvieh 
9-bp INDEL 
test +/- 
  
2822 Holstein 
9-bp INDEL 
test +/+ 
  
3850 Holstein 
9-bp INDEL 
test +/+ 
  
4171 Holstein 
9-bp INDEL 
test +/+ 
  
4356 Holstein 
9-bp INDEL 
test +/+ 
  2527 Holstein NK2B test 
 
T + 
3069 Holstein NK2B test 
 
T + 
3084 Holstein NK2B test 
 
T + 
3153 Holstein NK2B test 
 
T + 
3489 Holstein NK2B test 
 
T + 
3532 Holstein NK2B test 
 
T + 
3540 Holstein NK2B test 
 
T + 
3611 Holstein NK2B test 
 
T + 
3612 Holstein NK2B test 
 
T + 
3803 Holstein NK2B test 
 
T + 
3856 Holstein NK2B test 
 
T + 
4454 Holstein NK2B test 
 
T + 
2796 Holstein NK2B test 
 
T + 
3443 Holstein NK2B test 
 
T + 
3022 Holstein NK2B test 
 
T + 
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Table 7. Continued 
Individual Breed Utilization 
9-bp 
INDEL 
SNP 
(BovineHD1100014441) NK2B 
3318 Holstein NK2B test 
 
T + 
4378 Holstein NK2B test 
 
T + 
2822 Holstein NK2B test 
 
C - 
4171 Holstein NK2B test 
 
C - 
4494 Holstein NK2B test 
 
T + 
3850 Holstein NK2B test 
 
C - 
4356 Holstein NK2B test 
 
C - 
23 Brahman 
Gene 
conversion  
   
26 Brahman 
Gene 
conversion  
   
43 Charolais 
Gene 
conversion  
   
44 Charolais 
Gene 
conversion  
   
47 Charolais 
Gene 
conversion  
   
70 Gelbvieh 
Gene 
conversion  
   
91 Red Angus 
Gene 
conversion  
   
92 Red Angus 
Gene 
conversion  
   
93 Red Angus 
Gene 
conversion  
   
3850 Holstein 
Gene 
conversion        
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Results 
A 9-bp deletion in the third exon of NK1 causes a 3-aa deletion in the peptide  
Two referenced mRNA sequences (NM_001046578 and XM_010810081) were 
annotated for the gene LOC616323 (Gene ID: 616323) in the NCBI database which 
corresponds to our newly annotated NK1 gene. Full coding sequences of the two 
referenced mRNAs were compared with the coding sequence of NK1 predicted from the 
PacBio sequencing result (Fig. 20), and two INDELs with the lengths of 9-bp and 27-bp 
were revealed. In order to confirm the authenticity of these two INDELs in the coding 
region of NK1 gene, a pair of primers NK1-CDS whose amplicon spans both INDEL 
sites was tested in the cDNA prepared from four different individuals. Among four 
individuals, one was homozygous for the 9-bp deletion (Fig. 21A), two were 
heterozygous for this variant (Fig. 21B) and one was homozygous for the presence of 
this 9-bp on both chromosomes (Fig. 21C). Since we did not have the genomic 
information for the four tested individuals, we sequenced the genomic fragment 
spanning exon 2 – intron 2 – exon 3 of NK1 in nine more individuals to identify the 
corresponding genomic location of this 9-bp variant (Table 7). Individual 70 was the 
only one carrying the 9-bp deletion while the rest were all homozygous for the presence 
of this 9-bp fragment. By comparing with the genomic sequence extracted from BAC 
assembly which contains the 9-bp deletion, we were able to identify the location of this 
INDEL in the third exon of NK1. However, the 27-bp deletion was not detected in any of 
the four tested individuals. 
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Figure 20. Full coding sequence comparison between two referenced NK1 mRNAs 
extracted from the NCBI database (NM_001046578 and XM_010810081) and the 
sequence (NK1(PacBio)) predicted from the PacBio sequencing result. Red color 
indicates alignment with high consensus and blue represents alignment with low 
consensus. 
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Figure 21. A 9-bp INDEL (TGGTGCTCC) in the coding region of bovine NK1 gene. (A) 
Individual homozygous for the deletion. (B) Individual heterozygous for the deletion.  
(C) Individual homozygous for the presence of this 9-bp fragment. Black arrow (↑) 
indicates the INDEL site and horizontal black arrow (↔) represents the 9-bp INDEL 
(TGGTGCTCC). 
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Gene conversions within the bovine NK-lysin gene family  
We employed the method of shared polymorphisms to study the potential gene 
conversion events and their contributions to the high sequence identity among NK2A, 
NK2B and NK2C genes. Specific primers for each NK2 gene were tested in different 
individuals and the amplicons were compared with the corresponding region from the 
other two NK2 genes (Fig. 22). Two gene conversion events were identified within the 
893-bp amplicon of NK2A gene, and these two events were in linkage disequilibrium. 
The minimum conversion tract of the first event was 57 bp with NK2B being the donor 
gene while the second one was 154 bp with NK2C being the donor (Fig. 22 A, B). A 
gene conversion event with the minimum tract of 22 bp was also found in the 1479-bp 
amplicon of NK2B gene, and the NK2C was the donor. However, we were not able to 
detect any gene conversion events within the 891-bp amplicon of NK2C gene.  
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    (C) 
 
 
Figure 22. Gene conversion events within the bovine NK-lysin gene family. (A) (B) 
Amplicons of NK2A in individuals 92, 70, 3850, 93 and 44 were compared with the 
corresponding regions of NK2B and NK2C from L1 Domino 99375. All sequences were 
aligned to the NK2A (Domino). (C) Amplicons of NK2B in individuals 43, 47, 26, 23, 
93, 91 and 70 were compared with the corresponding regions of NK2A and NK2C from 
L1 Domino 99375. All sequences were aligned to the NK2B (Domino). Red boxes 
represent the minimum gene conversion tracts. 
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Copy number variation of NK2B in Holstein cattle  
Since NK2A, NK2B and NK2C genes arose by tandem duplications and share high 
sequence identity to each other, this is a candidate region for unequal crossovers to occur 
during meiosis resulting in copy number variation of bovine NK2 genes. To further 
confirm the authenticity of three NK2 genes as well as the potential copy number 
variation of each gene, we designed a pair of primers (Bo-lysin) from the conserved 
region of three NK2 genes. To minimize effects of allelic variation in the analysis, we 
selected four Holstein cattle homozygous for this region based on GWAS genotyping 
results with the 770K HD SNP array [167]. The SNP array contained 29 SNPs between 
the two genes flanking the NK-lysin region, ATOH8 [Gene ID: 616225] and SFTPB 
[Gene ID: 507398]. The PLINK program was utilized to identify individuals which were 
homozygous at all 29 SNP sites, and four cattle (2527, 2796, 2822 and 3850) with 
different haplotypes were selected for further analysis (Table 8). The number of the 
sequenced clones and different sequences obtained from each individual are listed in the 
Table 9. In total, five different sequences (Seq1-5) were recovered from these four 
individuals. The five sequences formed three clades, corresponding to the NK2A, NK2B 
and NK2C genes, and were divergent from NK1 (Fig. 23). Three different arrangements 
of NK-lysin genes were observed in this study. In the NK2A cluster, two sequences from 
individual 2527 were detected. If the individual 2527 was homozygous across the NK-
lysin region, then at least two copies of NK2A were present in this animal. Despite the 
large number of sequenced clones from both individuals 2822 and 3850, we found no 
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NK2B-related clones, and we could not obtain NK2B amplicons with NK2B specific 
primer (Gs-NK2B), which suggested the absence of the NK2B gene in these animals.  
 
 
Table 8.  Haplotypes of Holstein cattle homozygous across the entire NK-lysin region. 
Different colors represent different haplotype structures. 
 
 
 
 
 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29
2527 B B B A B B B A B A A A B B A A B B A B A A B A A B A A A
3069 B B B A B B B A B A A A B B A A B B A B A A B A A B A A A
3084 B B B A B B B A B A A A B B A A B B A B A A B A A B A A A
3153 B B B A B B B A B A A A B B A A B B A B A A B A A B A A A
3255 B B B A B B B A B A A A B B A A B B A B A A B A A B A A A
3302 B B B A B B B A B A A A B B A A B B A B A A B A A B A A A
3472 B B B A B B B A B A A A B B A A B B A B A A B A A B A A A
3489 B B B A B B B A B A A A B B A A B B A B A A B A A B A A A
3532 B B B A B B B A B A A A B B A A B B A B A A B A A B A A A
3540 B B B A B B B A B A A A B B A A B B A B A A B A A B A A A
3611 B B B A B B B A B A A A B B A A B B A B A A B A A B A A A
3612 B B B A B B B A B A A A B B A A B B A B A A B A A B A A A
3803 B B B A B B B A B A A A B B A A B B A B A A B A A B A A A
3856 B B B A B B B A B A A A B B A A B B A B A A B A A B A A A
4454 B B B A B B B A B A A A B B A A B B A B A A B A A B A A A
2796 B B B A B B B A B A A A 0 B A A B B A B A A B A A B A A A
3170 B B B A B B B A B A A A 0 B A A B B A B A A B A A B A A A
3443 B B B A B B B A B A A A 0 B A A B B A B A A B A A B A A A
3022 A A A B A B B A A A A A B B A A 0 B B B A A B A A A B A A
3318 A A A B A B B A A A A A B B A A 0 B B B A A B A A A B A A
4378 A A A B A B B A A A A A B B A A 0 B B B A A B A A A B A A
2822 A A A B A B B A A A A B B B A B B B A B A A B B B B A A A
4171 A A A B A B B A A A A B B B A B B B A B A A B B B B A A A
4494 B B B A B B B A B B A A B B A A B B A B A A B A A B A A A
3850 A B B B B A A B B B B B B B A B B B A B A A B B B B A A A
4356 A B B B B A A B B B B B B B A B B B A B A A B B B B A A A
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Table 9. Number of sequenced clones and different sequences obtained from each 
individual in the analysis of homozygous cattle. 
 
       Animal ID No. sequenced clones No. different clones 
2527 18 4 
2796 30 3 
2822 39 2 
3850 30 2 
 
 
 
 
 
 
Figure 23. NK2A, NK2B and NK2C nucleotide sequence analysis in four homozygous 
individuals (2527, 2796, 2822 and 3850). Five different clone sequences from four 
individuals (Seq 1 - 5) were phylogenetically analyzed with four bovine NK-lysin 
reference sequences (NK1, NK2A, NK2B and NK2C) and corresponding pig (Pig-NKL) 
and horse (Horse-NKL) orthologs by MEGA 6.0. Bootstrap values are shown at branch 
points. 
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Deletion of NK2B in Holstein cattle is in linkage disequilibrium with a SNP from the 
770K HD SNP array  
A total of 26 Holstein cattle with 6 different haplotypes were identified as homozygous 
for all the 29 SNPs within the bovine NK-lysin region (Table 8). The position of the 16
th
 
SNP (BovineHD1100014441, T/C) is Chr. 11: 49093033, which is 2429 bp upstream of 
the NCBI annotated LOC104968634 gene (Gene ID: 104968634) corresponding to 
NK2B. Individuals 2527 and 2796 with NK2B gene from the homozygous analysis 
showed genotype A at the 16
th
 SNP while individuals 2822 and 3850 without NK2B 
showed genotype B at this SNP site. To verify the linkage of NK2B with this SNP, we 
genotyped the NK2B by PCR with the Gs-NK2B primers in more individuals and the 
result revealed the complete linkage of NK2B deletion with the genotype B at the 16
th
 
SNP site among all the tested individuals (Table 7).   
 
Discussion 
Although often small in size, the pro-region is an important part of a precursor protein 
and plays a multifaceted role required for the maturation of an active protein. A 9-bp 
INDEL in the third exon of the bovine NK1 gene causing a 3-aa deletion in the pro-
region of the protein was identified in this study. Further studies are therefore suggested 
to investigate the effects of this 3-aa deletion on protein folding, secretion and 
antimicrobicities. Another genetic variant identified within the bovine NK-lysin family 
was the copy number variation of NK2B which is in linkage disequilibrium with a SNP 
from the bovine 770K HD SNP array. Also, it is clear from the homozygous analysis 
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that deletion of NK2B was not linked with the deletion of the other two NK2 genes, 
indicating that three NK2 genes were not located within the same copy number variation 
region (CNVR). It will be interesting to test the copy number variations of other bovine 
NK-lysin genes and their linkage with SNPs from the bovine 770K HD SNP array. Since 
thousands of cattle including both beef and dairy cattle have been genotyped with the 
770K HD SNP array and phenotypes scored for BRD symptoms 
(http://www.brdcomplex.org/), the newly identified genetic variants in this study could 
be incorporated together with the SNP genotypes to analyze the haplotype structures and 
investigate the linkage disequilibrium within the bovine NK-lysin region. Haplotype – to 
– phenotype association study could then be performed to identify the haplotypes 
associated with host resistance to bovine respiratory diseases. On the other hand, 
haplotype structures could also be studied in different breeds of cattle to gain insights 
into the evolutionary history of the NK-lysin region in breed differentiation.    
 
 
 
 
 
 
 
 
 
 96 
 
CHAPTER VI 
DISCUSSION AND CONCLUSIONS 
 
Discussion 
A single copy of the NK-lysin gene is annotated in the genomes of most mammals 
including humans, but our study identified a family of NK-lysin genes in cattle, 
consistent with the numerical expansion of other immune-related genes in the cattle 
genome, including interferons, defensins and cathelicidins. These expansions may 
reflect an evolutionary strategy to deal with the substantial numbers of pathogens and the 
increased risk of infections in the rumen of cattle. Therefore, a single copy of the NK-
lysin has also likely evolved into a gene family in other ruminant species. Two NK-lysin 
mRNA sequences were annotated in the NCBI nucleotide database for each of the 
ruminant species, including the water buffalo, sheep, goat and bison. Phylogenetic 
analysis revealed that one mRNA sequence from each species was clustered with the 
bovine NK1 gene while the other one was clustered with the bovine NK2 genes (Fig. 24). 
A pair of primers (Con-NK2 F: AGATTTGATGGACCCGAGCA, R: 
GTGAAACTATGGTTC TGGTGATGA) was designed within the conserved region of 
three bovine NK2 genes and recovered a NK2-related amplicon in several other ruminant 
species, including elk, white tail deer, swamp buffalo and gaur. Whether all ruminant 
species contain single copies of NK1 and NK2 or a single copy of NK1 plus three copies 
of NK2 genes needs to be determined. Re-sequencing the NK-lysin region with PacBio 
SMRT technology is suggested to investigate the genomic organization of this gene 
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family in ruminant species to gain insights into the evolutionary history of the gene 
family expansion.  
 
 
 
 
 
Figure 24. Phylogenetic analysis of the full coding sequences of four bovine NK-lysins 
and NK-lysin orthologs in humans, pig, horse, sheep, goat, water buffalo (WB) and 
bison. The accession number for each sequence in the NCBI nucleotide database is 
indicated and the bootstrap values are shown at branch points. 
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During gene family expansion, the ancestor gene usually maintains the original 
biological function, while the duplicated genes become pseudogenes or are free from 
purifying selection and may eventually evolve into genes with novel functions. All four 
bovine NK-lysin genes are expressed, albeit with different expression levels and in 
different tissues. Both expression assays and RNA-seq data revealed high expression of  
the NK2C gene in lung indicating its gain of a novel function in the bovine respiratory 
system. Further studies could be performed to compare the regulatory sequences of 
NK2C with other NK-lysin paralogs to identify the elements responsible for the high 
expression of NK2C in lung. In this study, gene expression was only tested in five 
tissues. It would be important to determine expression of bovine NK-lysins in more 
tissue types to investigate the potential novel functions of other duplicated genes.  
 
We also confirmed the antimicrobicity of the functional region helices 2 & 3 of each 
bovine NK-lysin peptide against both Gram-positive and Gram-negative bacteria. Each 
peptide possesses a specific property, including the charge, hydrophobicity and 
amphipathicity, which might enable the bovine NK-lysin family to be active against a 
broad spectrum of microorganisms. Although the bacterial killing assays showed 
relatively weaker antimicrobial activities of the synthetic NK2B peptide against all six 
tested bacterial strains, it is possible that NK2B has different targeted microorganisms. 
The activities of four peptides should be tested against more bacterial strains to identify 
the specific targets of each NK-lysin gene. 
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In Chapter V, our preliminary studies identified several genetic variants within the 
bovine NK-lysin region, including copy number polymorphism for NK2B in Holstein 
cattle and a 9-bp INDEL in the third exon of NK1 gene causing deletion of 3 amino acids 
in the pro-region of NK1 protein. Further studies should be performed to test the effects 
of these two variants on gene function. It will be important to investigate additional NK-
lysin genetic variants and their associations with host resistance as candidates to improve 
animal health. However, a big challenge of studying this gene family is the high 
sequence identity shared by the three NK2 genes. Extra care must be taken to distinguish 
allelic variation from paralogous variation.   
  
Conclusion 
Seven different NK-lysin related mRNA sequences in four phylogenetic clusters were 
identified in the NCBI bovine nucleotide database, suggesting the existence of multiple 
copies of NK-lysin genes in the cattle genome. This project focused on both the genetic 
and functional characterization of bovine NK-lysins. As described in CHAPTER II, two 
BAC clones covering the whole bovine NK-lysin region were sequenced with PacBio 
SMRT sequencing technology, and four NK-lysin genes were identified, NK1, NK2A, 
NK2B and NK2C. NK2A, NK2B and NK2C are tandemly arrayed as three copies in 30 ~ 
35 Kb segments, located 41.8 Kb upstream of NK1. Analysis of repeat element revealed 
that fragments flanking each breakpoint share high homology, and could contribute to 
the gene family expansion as well as potential unequal crossover during meiosis and 
structural instability within the bovine NK-lysin gene family. CHAPTER III describes 
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the expression profiles of the four identified bovine NK-lysin genes in five different 
tissue types, and the effects of the synthetic peptides corresponding to the functional 
helices 2 & 3 of each gene product on both model membranes and bacterial membranes. 
Different from the other NK-lysin paralogs and orthologs, bovine NK2C is highly 
expressed in lung, indicating the evolution of a novel function in the bovine respiratory 
system. The disruptive effects of bovine NK-lysin peptides on the anionic model 
membrane and bacterial membrane were also confirmed in this study, consistent with the 
antimicrobial effects of other positively charged AMP molecules. Since NK2C shows a 
high expression level in lung, we investigated the potential function of bovine NK-lysins 
in host resistance to bovine respiratory pathogens as described in CHAPTER IV. 
Expression levels of each bovine NK-lysin gene in bronchial lymph node and lung were 
compared between control animals and animals challenged with different BRD-
associated pathogens by analyzing RNA-seq data. The expression of several NK-lysins, 
especially NK2C, was elevated in challenged relative to control animals, indicating its 
potential importance in host defense against pathogens involved in bovine respiratory 
disease. Antimicrobial effects of the bovine NK-lysin peptides on BRD-causing 
Pasteurella multocida and Mannhemia haemolytica bacterial strains are also confirmed 
in this chapter. CHAPTER V describes some identified genetic polymorphisms within 
the bovine NK-lysin region, including a 9-bp INDEL in the third exon of NK1 causing a 
3-aa deletion in the pro-region of the peptide and the deletion of NK2B in some Holstein 
cattle. Evidence for gene conversion events were also found among three NK2 genes, 
which might explain the high sequence identity shared by these three genes.  
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In conclusion, this study is the first to clarify the organization and structure of the NK-
lysin gene family in the cattle genome and provide a foundation for future studies of NK-
lysin genes in maintaining the health of cattle as well as other ruminant species.   
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APPENDIX  
PHOSPHORUS ASSAY PROTOCOL 
 
Reagents:  
Sulfuric acid (H2SO4) (SIGMA-ALDAICH, cat # 339741-100ML) 
Ammonium molybdate tetrahydrate (SIGMA-ALDAICH, cat #09878-25G) 
L-Ascorbic acid (SIGMA-ALDAICH, cat # A5960-25G) 
0.65 mM Phosphorus standard solution (SIGMA-ALDAICH, cat # P3869-25ML) 
Hydrogen peroxide (SIGMA-ALDAICH, cat # 216763-100ML) 
 
Procedure: 
Prepare the solutions 
1, 8.9 N H2SO4 solution: 247 ml of H2SO4 is slowly mixed with 753 ml of deionized 
water. This solution can be stored at room temperature.  
2, 10% Ascorbic acid solution. 10 g of ascorbic acid is dissolved into 100 ml of 
deionized water. This solution should be stored in an amber screw-cap bottle at 4°C 
before use.  
3, 2.5% Ammonium molybdate tetrahydrate solution. 2.5 g of ammonium molybdate 
tetrahydrate is dissolved into 100 ml of deionized water. This solution should be stored 
in an amber screw-cap bottle at 4°C before use.  
 
Prepare the sample tubes 
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Sample containing about 0.1 µmoles phosphorus is placed into the bottom of a tube, and 
the solvent is gently removed from the tubes with N2. Three technical replications are 
performed. 
 
Prepare the standard tubes 
Six standard tubes containing known quantities of phosphorus are prepared by placing 
the phosphorus standard solution into six separate tubes: 0 µmoles (0µl) blank, 0.0325 
µmoles (50 µl), 0.065 µmoles (100 µl), 0.114 µmoles (175 µl), 0.163 µmoles (250 µl), 
and 0.228 µmoles (350 µl). 
 
Digestion of organic sample to inorganic phosphate 
1, An aliquot of 0.45 ml 8.9 N H2SO4 is added to each of the standard tubes and sample 
tubes. 
2, All the tubes are heated in an aluminum block in the hood at 200-215°C for 25 
minutes.  
3, Tubes are removed from the block and cooled at room temperature for 5 minutes 
before added with an aliquot of 150 µl H2O2 to the bottom of each tube. 
4, Tubes are heated for an additional 30 minutes in the same aluminum block in the hood 
at 200-215°C. The samples should be colorless at this point. If any brown color persists, 
another aliquot of 50 µl H2O2 can be added to all the cooled tubes and the tubes 
continue to be heated for another 15 minutes. 
5, An aliquot of 3.9 ml deionized water is added to each cooled tube. 
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6, An aliquot of 0.5 ml ammonium molybdate tetrahydrate solution is added to each 
tube, and tube is vortex for 5 times. 
7, An aliquot of 0.5 ml 10% ascorbic acid solution is added to each tube, and tube is 
vortex for 5 times. 
8, All tubes are heated at 100°C for 7 minutes in an aluminum block in the hood. 
9, Tubes are cooled to the ambient temperature. 
 
Spectrophotometric analysis of samples 
1, Spectrophotometer is standardized using the 0 µmoles standard solution. 
2, The absorbance of each of the five standards is measured at 820 nm.  
3, The absorbance of each of the samples is measured at 820 nm. 
4, The calibration curve is determined by using the standards, and concentration of 
phosphorus in the samples are calculated based on the calibration curve. 
 
 
 
 
 
 
 
